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7 A. Abstract 
A. Abstract 
Melanoma is a malignant tumor in which UVA (320-400nm) radiation is regarded to 
be an important risk factor. To date, the role of UVA in melanoma progression 
towards an invasive phenotype is still not adequately investigated. For most 
proliferating tumor cells the preference of aerobic glycolysis has been described as 
the Warburg effect. Here we examine the effect of UVA irradiation on changes in 
Warburg effect and tumor progression towards invasive potential. Upon UVA 
irradiation, melanoma cell lines from initial tumors show an induction of the Warburg 
effect with increased glucose consumption and lactate production, which is at least 
partially mediated by reactive oxygen species (ROS). Concomitantly with UVA 
treatment and the enhanced lactic acid production, tumor relevant proteases and in 
situ invasion is upregulated. Simultaneously, UVA increases intracellular 
concentrations of the progression markers transketolase and activated protein kinase 
Akt, both involved in metabolic changes that can be enhanced with proliferation. By 
using invasion assays we show that lactic acid, resulting from the UVA enhanced- 
and partially ROS mediated Warburg effect, increases the invasive potential of all 
melanoma cell lines investigated. Therefore, we recognize in melanoma cells, that 
production of lactic acid, induced by UVA irradiation, increases invasiveness of 
melanoma cells via expression of tumor relevant proteases. Additionally, we 
investigated the influence of UVA irradiation on initial melanoma and metastasizing 
melanoma in a 3D skin reconstruct model. Again, this UVA irradiation was able to 
increase the Warburg effect (glucose consumption and lactate production) and the 
transketolase activity and these effects were partially mediated by ROS. 
Furthermore, UVA treatment increased MMP9 and uPA expression and UVA 
treatment increased the invasion of melanoma cells in the skin reconstruct, which 
was verified by a histopathologist (section from Baban et al., in press).  
Mitochondrial DNA (mtDNA) common deletion could be implicated in the progression 
of various cancer types but it has not been investigated in progression of melanoma. 
To investigate the role of mtDNA 4977bp deletion in the development of melanoma, 
we analyzed mtDNA 4977bp deletion in patients with nevi and different stages of 
melanoma. There we detected a highly significant change in the frequency of mtDNA 
4977bp deletion. These findings could point to a selection mechanism against 
mtDNA 4977bp deletion, emphasizing the importance of functional mtDNA despite 
the observation of enhanced Warburg effect.  
  ! !!!!!!8! !! !
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B. Introduction 
1. Melanoma and ultraviolet radiation 
1.1 Epidemiological data on melanoma 
Melanoma is a malignant skin tumor deriving from melanocytic cells, characterized by 
high morbidity and mortality with a constantly rising incidence (Howe et al., 2001; 
Jemal et al., 2010), recent data indicate that the prevalence rate rose up 5 fold during 
the last 3 decades worldwide (Leiter et al., 2014). It is estimated that 137,310 new 
cases of melanoma will be diagnosed and the lifetime risk rose to 1 in each 50 
people by 2015 in the United States (US) (Rigel et al., 2010; American cancer society 
cancer facts and figure, 2015) (figure 1). 
A parisian physician Rene Laennec’s had diagnosed and published the first case of 
melanoma in Europe approximately 210 years ago. There is substantial variation in 
melanoma rate within different ethnic population groups (Howe et al., 2001), reported 
data show an increase in incidence rate by 3-7% per year in Caucasian population 
(Jhappan et al., 2003). Melanoma is more common in fair skin types (Armstrong and 
Kricher, 2001) for example in the Scandinavian population, as their skin type 
expresses more pheomelanin (reddish yellow melanin) and less eumelanin (brownish 
black melanin). Eumelanin is a strong ultraviolet (UV) blocking pigment (Vincensi et 
al., 1998; Brenner and Hearing, 2008). The skin type represents one of the risk 
factors that influence melanoma development (John et al., 2013). Although 
melanoma may arise de novo, also there is a classical staging in melanoma 
development, where melanoma develop from initial tumor cells via radial growth 
phase (with tumor thickness less than 1mm patients mostly are cured after excision 
with surgery) and vertical growth phase (with tumor thickness more than 1mm, starts 
spreading to deeper layer of the dermis) to metastasizing melanoma (spreading to 
distant organs) (figure 2). One important aspect for prognosis and treatment is 
staging of melanoma, which depends on tumor thickness, mitotic rate, ulceration and 
metastasizing to lymph nodes and distant organs.  
Epidemiological evidence indicates that UV radiation is involved in the generation of 
melanoma with approximately 65% of melanoma being caused by UV radiation (Bald 
et al., 2014; Fears et al., 2002; Tucker and Goldstein, 2003; Klug et al., 2010; 
Armstrong and Kricker, 1993). Besides, some authors hypothesize a direct 
correlation between sunburn and the pathogenesis of melanoma (Dennis et al., 
2008).  
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                                                                                                              (Rigel et al.,  figure 1, 2010)                                                              
Figure 1. Lifetime risk of invasive melanoma. 
Increased lifetime risk of developing invasive melanoma in the US population from 1930 to 2015.  
 
  
 
 
                                                                                     (Modified from Miller and Mihm, 2006) 
Figure 2. Progression of melanoma. 
In the staging model, melanomas develop from benign nevi cells via radial growth phase and vertical 
growth phase to metastasizing melanoma. 
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1.2 UV radiation and human skin 
1.2.1 UV radiation 
UV radiation is an electromagnetic radiation with the main natural source being the 
sun. The main artificial source for UV radiation is the tanning bed. The solar UV 
radiation is subdivided into three types according to wavelength and energy 
(Mogensen and Jemec, 2010): 
- Ultraviolet A (UVA) has a wavelength between 320-400nm, which constitutes 
more than 95% of the solar UV radiation (Balk, 2011). 
- Ultraviolet B (UVB) has a wavelength between 280-320nm, which constitutes 
less than 1% of the solar UV radiation (Rastogi et al., 2010; Balk, 2011). 
- Ultraviolet C (UVC) has a wavelength between 100-280nm. It does not reach 
the surface of the earth because it is absorbed by the ozone layer in the 
atmosphere (Mogensen and Jemec, 2010).  
The Intensity of solar UV radiation on earth surface depends on many factors, like 
time of daily exposure, the season, the altitude, the latitude and the UV reflection on 
the surfaces (Battie and Verschoore, 2012). 
Another source of UV radiation is the tanning bed, which emits approximately (95%-
99%) UVA and (1%-5%) UVB (Mogensen and Jemec, 2010) and intensity of tanning 
is mostly 10 times higher than solar radiation during midday (Balk, 2011). Studies 
showed that the risk for developing melanoma is increased up to 75% when tanning 
devices were used before the age of 35 years  (Schulman and Fisher, 2009). 
Since 2009, the World health organization (WHO) classified UV radiation as one of 
the carcinogenic factors (Mogensen and Jemec, 2010). 
 
1.2.2 UV radiation effect on human skin 
Exposures to UV radiation with acute high doses or chronic doses are considered as 
a risk factor for human body with profound change in the aging process and in 
tumorigenesis of the human skin (John et al., 2013).  
The long wavelength UVA radiation has the ability to penetrate the epidermis as well 
as the dermis and partially can reach the subcutaneous layer. UVA radiation mainly 
absorbs and induces damage in the dermis but UVB radiation penetrates the 
epidermis and upper layer of the dermis and it mostly absorbs and induces damage 
in the epidermis (Lee et al., 2013) (figure 3). 
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           Ultraviolet radiation            Visible light              Infrared radiation 
Wavelength   280nm      320nm                   400nm                                                      780nm                                                                                    
                  
                    UVB         UVA 
 
 
 Epidermis 
 
 Dermis 
 
Subcutanous 
         
 
Figure 3. UV penetration in human skin. 
UVA can penetrate the epidermis and dermis and UVB mainly penetrates the epidermis, both visible 
light and infrared radiation are capable to penetrate deeper than UV radiation.  
 
1.2.3 Physiological relevance of UV radiation 
Solar radiation has a wide range of biological effects. On the cellular level the energy 
of UVB radiation is absorbed by proteins and DNA molecules, causing direct DNA 
damage and mutations (Rastogi et al., 2010). The best described types of DNA 
damage, which are caused by UVB radiation, are cyclobutyl pyrimidine dimers 
(CPDs) and 6-4 photoproducts (6-4PPs) (Setlow et al., 1993; Douki et al., 2003; 
Besaratinia et al., 2004; Pfeifer et al., 2005), leading to genetic transitions.  
UVA radiation is not significantly absorbed by DNA but it predominately induces the 
formation of reactive oxygen species (ROS) (Wittgen and Kempen, 2007; Beissert 
and Loser, 2008; Kappes et al., 2006). ROS are able to cause DNA damage, which 
can cause mutations, single strand breaks (SSBs) or double strand breaks (DSBs) in 
cellular DNA molecules (Wehner et al., 1995; Folkard et al., 2002). One of the most 
described UVA induced photoproduct in human skin is 8-oxo-7,8-dihydro-2'-
deoxyguanosine (8oxoG) (Mouret et al., 2006) (table 1).  
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Type of ultraviolet 
radiation 
                
                UVB 
  (direct DNA damage) 
                  
                 UVA  
 (indirect DNA damage) 
 
 
 
 
         
          
            DNA damage  
 
Cyclobutyl pyrimide 
dimers (CPDs):          
 -TT dimers 
 -TC/CT dimers 
 -CC dimers 
 
 
Pyrimidine-pyrimidone 
  6-4 photoproducts 
  (6-4PPs) 
 
 
Single strand breaks 
(SSBs) 
 
Double strand breaks 
(DSBs) 
 
 
7,8-dihydro-8-oxo-2′-
deoxyguanosine 
(8oxoG) 
 
8-oxo-Adenin (8oxoA)  
 
 
      Some  consequence 
         of DNA damage 
 
 
C-T or CC-TT transitions 
 
 
T-G transversions  
 
  
Table 1. DNA damage and consequence of DNA damage induced by UVB and UVA radiation. 
 
  
1.3 Reactive oxygen species  
Reactive oxygen species (ROS) are chemically reactive molecules, which are derived 
from oxygen (O2) such as super oxide anions, hydroxyl radicals and peroxides 
(Poillet-Perez et al., 2014). They can be formed endogenously by mitochondria via 
the electron transport chain and during mitochondrial dysfunction (Liemburg-Apers et 
al., 2015) and additionally through nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase enzymes (NOX) and uncoupling of nitric oxide syntheses (NOS) 
(Liu-Smith et al., 2014). Furthermore, ionizing radiation (IR), ultraviolet radiation (UV) 
and visible light are exogenous sources of ROS (Jalal et al., 2014).            
Detoxification of ROS is mediated by a number of defence mechanisms to achieve a 
balance between the production and the removal of ROS. An imbalance towards the 
pro-oxidative state is often referred to as “oxidative stress”. 
Mechanisms of ROS detoxification are: 
1. Enzymatic defence system against ROS, which is catalyzed by super oxide 
dismutase (SOD) and glutathione peroxidase.  
  ! !!!!!!13! !! !
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2. Non Enzymatic defence systems against ROS are induced by antioxidant 
agents such as glutathione, vitamin C (ascorbic acid) and vitamin E (α-tocopherol) or 
Trolox (Khalid R, 2007). 
ROS is able to cause nuclear and mitochondria DNA damage, additionally, ROS is 
involved in tumor progression, migration and invasion (Poillet-Perez et al., 2014; 
Luanpitpong et al., 2010). A study performed in melanoma cells showed that over 
stimulation of NOX enzyme, especially NOX1 enzyme, led to the enhancement in the 
expression of matrix metalloproteinase 9 (MMP9) and matrix metalloproteinase 2 
(MMP2) and enhanced invasion in vitro (Liu et al., 2012). 
 
1.4 DNA damage repair 
Proper function and survival of all organisms depends on genome maintenance. A 
constant DNA damage from genotoxic agents is challenging several repair 
mechanisms for genome integrity. Besides, DNA damage can also occur during DNA 
replication, such as nucleotide misincorporation (Lindahl et al., 1993; Jackson et al., 
2010). 
Human cells counteract these threatening lesions by several efficient systems, which 
participate to detect DNA damage and mediate its repair such as base excision repair 
(BER), nucleotide excision repair (NER), mismatch repair, DNA strand repair 
mechanisms (non homologous end joining (NHEJ) and homologous recombination 
(HR)) (Zhang et al., 2009). 
Failure or incorrect repair of DNA lesions blocks genome replication and 
transcription, leading to mutations or different genomic aberrations that threaten cell 
functions and organisms viability. There are several diseases caused by DNA 
damage in humans, such as cancers and genetically inherited disorders 
(Hoeijmakers, 2001; Peltomaki et al., 2001), which are caused by defects in the DNA 
repair system, like in Xeroderma pigmentosum (XP) disease.    
 
1.5 Oxidative stress and mtDNA mutagenesis caused by UV radiation 
Mitochondrial DNA (mtDNA) consists of circular double stranded DNA, which has 
16.5 kilobases (kb)s. The mitochondrial genome has 37 codes for the genes, which 
are important for normal mitochondrial function (Taanman, 1999), coding for 13 
polypeptide genes provide protein instructions for complex Ι, ΙΙΙ, ΙΙΙΙ and ΙΙΙΙΙ, which 
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are involved in oxidative phosphorylation and the remaining genes code for transfer 
RNA (tRNA) and ribosomal RNA (rRNA), which are necessary for protein synthesis.  
Histones in the nuclear DNA are necessary for nuclear packing and act against 
genetoxic events. Therefore, a lack of histone proteins in mitochondria can cause 
high rates of mtDNA mutagenesis, which is nearly 10 fold increased in mitochondrial 
DNA compared to nuclear DNA (nDNA) (Ballard and Whitlock, 2004; Tatarenkov and 
Avise, 2007).  
As a major environmental factor, solar UV irradiation induces oxidative stress, which 
promotes mtDNA mutations through ROS, like mtDNA common deletion (Berneburg 
et al., 1997; Berneburg et al., 2004; Kaneko et al., 2012). Therefore, mutation of 
mtDNA probably serves as a biomarker for cumulative UV radiation exposure and it 
has been shown, that mtDNA mutation is correlated with photoaging rather than 
chronological aging (Birch-Machin et al., 1998; Gendron et al., 2012) and UVA 
induced mtDNA mutation can persist even for more than 1.5 year (Berneburg et al., 
2004). 
The role of mutated mtDNA in the different tumors and in the different stages still is 
discussed controversially.  
 
1.6 Common deletion of melanoma mtDNA 
One of the best documented common mutation in mitochondrial DNA (mtDNA) 
molecules is a 4977bp deletion, which is also known as common deletion (Kamenish 
et al., 2006), normally correlated with the aging process or found in diseases, 
especially in premature skin aging (photoaging), which is associated with UV 
radiation (Berneburg et al., 2000) and cancer. 
Various studies reported higher frequency of mtDNA common deletion in 
sunexposed sites, compared to sunprotected sites, in normal aged skin (Pang et al., 
1994; Berneburg et al., 1997; Birch-Machin et al., 1998). 
High metabolic activity and low proliferation rate in the tissues like heart, brain and 
muscle, accelerate the accumulation of mtDNA common deletion in contrast to fetal 
and young tissues (Cortopassi and Arnheim, 1990; Wallace et al., 1992; Bogliolo et 
al., 1999). As mtDNA mutations are important issues in carcinogenesis (Eshaghian et 
al., 2006), the frequency of mtDNA common deletion was investigated in various 
carcinomas. While some publications have found no changes in mtDNA mutation, 
others showed change in the frequency of mtDNA mutation in different tumors, in 
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breast cancer, gastric cancer, prostate cancer, colon carcinoma and head and neck 
cancer the frequency of mtDNA common deletion are compared with normal tissue, 
which are almost reduced or absent (Heerdt and Augenlicht, 1990; Fukushima et al., 
1995; Habano et al., 1998, 1999; Kotake et al., 1999; Shieh et al., 2004; Dani et al., 
2004), furthermore, in some tumors for example in oral cancer and colorectal cancer 
it has been shown that the frequency of deleted mtDNA is declining proportionally 
during disease progression (Shieh et al., 2004; Chen et al., 2011).  
Up to now, there is a critical discussion about the level of mtDNA common deletion, 
which was found in different carcinomas. 
It is known that UVA radiation induces skin tumors and it can also induce mtDNA 
common deletion (Berneburg et al., 1999). In this context, it was important to 
investigate the mtDNA common deletion in skin cancer. 
This was partially investigated in non melanoma skin cancer or in squamous cell 
carcinoma (SCC) and basal cell carcinoma (BCC). Previous work of our group 
showed a tendency of decreased in the level of mtDNA common deletion in (SCC) 
and (BCC) compared to surrounding tissues of these tumors (Kamenisch et al., 
2007).  
It has been reported in normal skin (non tumor) tissue of melanoma patients, that the 
level of mtDNA common deletion was associated with pigmentation of melanoma 
cells  (Hubbard et al., 2008).  
 
1.7 Induction of melanoma by UV in different models 
While it is clear, that UV radiation is one of the risk factor of squamous cell carcinoma 
(SCC) and basal cell carcinoma (BCC) (Ramos J et al., 2006) so far, the role of UVA 
and UVB radiation is discussed controversially. Furthermore, the role of UVB and 
UVA radiation in melanoma carcinogenesis is not clear and since in vivo data are 
important to support the role of UV in the development and progression of malignant 
melanoma, currently there are some studies on the formation of melanoma with and 
without UV radiation exposure in different animal models.  
 
1.7.1 Induction of melanoma without UV radiation 
There are animal models that develop melanomas without exposure to UV radiation, 
or due to other reason rather than UV radiation. In mammalian animals, like in 
Sinclair swine, a main reason for melanoma is due to genetic hereditary factors, while 
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the histopathology of metastasizing process is well defined and similar to the human 
skin (Gomez-Raya et al., 2007).  
In Camargue horses (gray skinned) melanoma can occur and the incidence rate of 
cutaneous melanomas tumors is high but it is significantly associated with age and 
93.9% of tumors are located in non sun exposed regions (Fleury et al., 2000); 
therefore, development of melanoma is not related to solar irradiation. 
Melanomas are described also in the Guinea pig and in the Syrian hamster models 
and these tumors are developed by the exposure to chemical carcinogen 7,12-
dimethyl benz anthracene (DMBA) (Bardeesy et al., 2000) but not by exposure to UV 
irradiation alone, although UV can be able to enhance response to (DMBA). 
 
1.7.2 Induction of melanoma with UV radiation 
UV induces melanoma in Opossum (Monodelphis domestica) (Ley, 1991), when 
exposed to chronic sub-erythemal dose (Bardeesy et al., 2000) but UVA alone was 
able to initiate melanocytic hyperplasia rather than malignant melanoma (Ley, 2001). 
However, opossum models are unsuitable to investigate, since the genetic pattern is 
poorly defined. Although difficulty to maintains this model limits the chance to use this 
model for genetic and immunologic study (Sabourin et al., 1992; Sherburn et al., 
1998; Linan et al., 2005), furthermore, melanomas are derived from the dermal layer 
and rarely are metastastic in contrast to the human malignant melanoma (Jhappen et 
al., 2003). 
In non mammalian animals, like Xiphophorus fish, melanoma are developed either 
spontaneously or upon UV irradiation (Walter and Kazianis, 2001), furthermore, it 
was shown in a backcrossed hybrid Xiphophorus fish model, that both types of solar 
UV radiation, UVB (it mainly induces direct DNA damage) and UVA (it mainly induces 
indirect DNA damage) are capable to initiate melanoma (Mitchell et al., 2007). Using 
this model to investigate melanomagenesis is difficult, because there are wide 
differences, both phylogenetic and histologic in human skin compared to 
Xiphophorus fish. 
Several years ago, different animal models were used to investigate the UV radiation 
as a causative factor for melanoma development. Recently, mice prominently are 
used to study melanomagenesis, because mouse genes are well described. But 
malignant melanomas are extremely rare in wild type mice and like other mammalian 
melanomas are derived from the dermis (not from the basal layer of the epidermis 
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like in human) because melanocytes are close to hair follicles and rarely 
metastasizes. Furthermore, there are only a few similarities in histopathology 
between mouse and human skin (Linanan et al., 2005). Currently, different models of 
transgenic mice are available, which are providing pivotal insight in the role of a 
number of key pathways in melanomagenesis, which can facilitated transformation of 
melanocytes to neoplastic lesions. These models are: over expression of activated 
Rat sarcoma (RAS) genes, cyclin dependent kinase 4 genes (cCdk4) and receptor 
tyrosine kinase (RTK) genes or their ligands and inactivation of tumor protein (p53) 
gene or phosphatase and tensin homolog (PTEN), among others.   
An early transgenic mouse model, which develop melanoma and shows UV radiation 
as reasonable cause is the transgenic mouse model for SV40 T-antigen described by 
(Kelsall and Mintz, 1998) and controlled by tyrosinase promoters (Bradl and Klein, 
1991). Since these models suffered from different effects of the SV40 T-antigen, 
several problems may arise when analysing the relevant pathways. 
One of the best-known transgenic mouse models, which is used for melanoma 
examination, is the hepatocyte growth factor/scatter factor (HGF/SF) mouse model, 
which will be described in detail in the next passage. 
 
1.7.3 Hepatocyte growth factor/scatter factor (HGF/SF) mice 
Recently, appropriate mouse models have been developed by Merlino and 
Colleagues (Marentt, 2000), in fact, all mouse models that have been mentioned 
before. In this model, the mouse is transgenic for a metallothionein (MET) gene 
promoter, which can be used to overexpress hepatocyte growth factor/scatter factor 
(HGF/SF). The c-Met is a multifunctional cytokine regulator, which is involved in 
different cellular behaviours that are related to tumorigenesis, like growth, motility and 
invasiveness (Comoglio and Boccaccio, 2001). 
In human oncogenesis, irregularity of c-Met signaling or over expression of c-Met 
receptors has been implicated in cutaneous melanoma (Natali et al., 1993; Jeffers et 
al., 1996). 
The HGF/SF transgenic mouse is characterised by: 
1- Akin to human melanocyte location, (HGF/SF) mouse melanocyte is localized 
in the epidermis or upper regions of the dermis and at the epidermal-dermal 
junction (Noonan et al., 2001; Recio and Merlnio, 2002). 
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2- Histopathological appearance, stage progression and pathogenetic molecular 
aspect resemble human melanoma, which are induced by UV irradiation 
(Noonan et al., 2001; Recio and Merlnio, 2002). 
With this transgenic mouse model it has been shown that UVB has an effect in 
initiating cutaneous melanoma (De Fabo et al., 2004), whereas UVA did not induce 
melanomas in a transgenic mouse model (HGF/SF) with an albino inbred background 
(De Fabo et al., 2004; Noonan et al., 2001). 
Interestingly, later on it has been demonstrated in the mice transgenic for (HGF/SF) 
with pigment-inbred background, that irradiation with a single neonatal high dose of 
UVA (Noonan et al., 2012) is capable to induce melanotic tumors (figure 4).  
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                                                                                                        (Modified from Jhappen et al., 2003) 
Figure 4. UV influence on induction of melanoma in HGF/SF transgenic mice. 
Melanoma in HGF/SF transgenic mice can be induced by UVB and UVA irradiation, but depends on 
type and dose of UV irradiation and on inbred background. 
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The latter study strongly supports the role of a single neonatal high dose of UVA 
radiation in the pathogenesis of melanoma. Furthermore, single neonatal UVA 
irradiation is mimicking sunburn reactions in childhood, but they do not mimic normal 
physiological UVA exposure, where humans are typically exposed to several low 
doses of solar UVA radiation.  
These models show clearly that UVA as well as UVB are cancer-promoting agents 
and are capable to induce melanoma. Still the question on the role of UVA in 
progression of melanoma remains unanswered.  
 
Two important points during progression of initial melanomas are invasion, which 
requires specific proteases and proliferation that requires specific metabolic 
demands, like the Warburg effect and increased transketolase activity.  
 
 
2. Glycolysis and tumor metabolism 
Glycolysis is an important metabolic pathway for energy production. It means 
conversion of glucose C6H12O6 to pyruvate CH3COCOO− in the cytoplasm. The first 
step is the phosphorylation of glucose by hexokinase enzyme, which is a key enzyme 
of the glycolysis pathway. Through this pathway, cellular energy in the form of 
adenosine triphosphate (ATP) and reduced nicotinamide adenine dinucleotide 
(NADH) are produced. Furthermore, pyruvate can be metabolized by two different 
pathways that are described in the next passage (Alfarouk et al., 2014) (figure 5 and 
6). 
 
2.1.1 Decarboxylation of pyruvate 
Preferably under aerobic condition, in this pathway pyruvate is degraded to acetyl-
CoA, and then enters the citric acid cycle, which occurs in the mitochondria matrix. 
Multiple enzymes are involved in completely oxidizing acetyl-CoA into carbon dioxide 
and a reducing agent NADH. 
NADH participates in oxidative phosphorylation, there it is oxidized to NAD+ and the 
electrons of NADH are transferred to an electron acceptor (oxygen O2 molecule) in 
the electron transport chain. The energy achieved in this process is stored in the 
proton gradient and used to produce ATP via the ATP synthase.  
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Moreover, the TCA cycle provides intermediate components, which are used as 
precursors for the biosynthesis of other molecules such as fatty acids and different 
amino acids (Lunt and Vander Heiden, 2011), the total cellular energy produced from 
1 mole of glucose is about 36 moles of ATP (figure 5). 
 
2.1.2 Anaerobic glycolysis 
Under hypoxic conditions, resting cells for energy production turn to anaerobic 
glycolysis instead of oxidative phosphorylation, because insufficient amount of O2 
limits ATP synthesis by the electron transport chain inside the mitochondria. 
In the cytoplasm, pyruvate is converted to lactate by lactate dehydrogenase enzyme 
(LDH) and in this process NADH is convert to NAD+, which is needed in glycolysis 
and also is involved in the continuous glucose flux through glycolysis by 
glyceraldehyde 3 phosphate to 1,3 bisphosphoglycerate transformation (Hamanaka 
and Chandel, 2012). Anaerobic glycolysis typically is seen in excess in skeletal 
muscles, when sufficient amount of oxygen is not available and in erythrocytes 
because they lack mitochondria. From 1 moles of glucose only 2 moles of ATP are 
generated (figure 5). 
 
2.1.3 Aerobic glycolysis or Warburg effect 
Many tumor cells prefer aerobic glycolysis for energy production, even if adequate 
amounts of O2 are present, this phenomenon is known as Warburg effect. It was 
discovered more than 80 years ago by Otto Heinrich Warburg (1883–1970), a 
German scientist, who laureate the Nobel prize in physiology (1931) for the discovery 
of the nature and mode of action of the respiratory enzyme. 
In oncology, Warburg focused on the metabolism and the respiration of cancer cells.  
He describes the metabolic preference of proliferating cells, as well as tumor cells, 
using high rate of glycolysis, followed by lactic acid fermentation in the cytosol for 
energy production, which is known as aerobic glycolysis (figure 5). Compared to the 
lower rate of glycolysis and subsequent oxidation of pyruvate in the mitochondria, as 
it occurs in resting cells. He assumed, that cancer is caused by dysfunctionality of the 
mitochondrial metabolism (Warburg, 1956). Meanwhile, different studies have shown 
the functionality of mitochondria (Frezza and Gottlieb, 2009) and the phenomenon of 
aerobic glycolysis would be only the metabolic demand of proliferative cells, such as 
tumor cells, which is necessary for their growth and proliferation, since they require 
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more metabolites in demand for nucleotide, lipid and amino acid formation (Zu and 
Guppy, 2004). 
Nowadays, the Warburg effect phenomenon is used in clinical diagnosis; a glucose 
analogue, such as fludeoxyglucose (18F) is used and detected by positron emission 
tomography, because fludeoxyglucose (18F) is taken up by high glucose consuming 
cells, like tumor cells (Gambhir, 2002). 
 
        
                                                                                      (Vander Heiden et al., 2009) 
Figure 5. Glucose metabolism in normal and tumor cells.                                                                                     
  
2.2 Tumor metabolism and pentose phosphate pathway  
Pentose phosphate pathway is the metabolic pathway occurring in the cytoplasm and 
generating NADPH and ribose sugars. NADPH acts as a reducing equivalent in the 
biosynthesis of lipids, nucleotides and amino acids. Pentose (5 carbon atoms) sugars 
are important for nucleotides and nucleic acid synthesis. 
The pentose phosphate pathway generally consists of 2 phases (Patra and Hay 
2014): 
 
2.2.1 Oxidative phase: Glucose 6-phosphate is converted to ribulose 5-phosphate 
and NADP+ is reduced to NADPH (figure 6). 
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Reaction:                       glucose 6-phosphate + 2 NADP+ + H2O  
         
                                   
                                 ribulose 5-phosphate + 2 NADPH + 2 H+ + CO2 
 
2.2.2 Non-oxidative phase: from ribulose 5-phosphate, ribose-5-phosphate and 
intermediate glycolysis compounds are generated to fuel the glycolysis pathway 
(figure 6).  
 
Reaction:                                 3 ribulose-5-phosphate 
   
                                
                               1 ribose-5-phosphate + 2 xylulose-5-phosphate   
 
                              
                          2 fructose-6-phosphate + glyceraldehyde-3-phosphate 
 
2.2.3 Transketolase like 1 enzyme 
Transketolase like 1 (TKTL1), an isoenzyme of the transketolase (Schenk et al., 
1998), is a key enzyme of the pentose phosphate pathway (Berthon et al., 1992), as 
mentioned before it provide cells with components that are crucial for proliferation, 
survival and nucleotide synthesis in the non oxidative phase of the pentose 
phosphate pathway, like ribose sugar (Koolman and Röhm et al., 1998) (figure 6). 
An increase in TKTL1 is another metabolic change, found in many tumor cells 
including melanoma, which is therefore used as a tumor biomarker for highly 
proliferative cancers (Diaz-Moralli et al., 2011; Langbein et al., 2006) and as indicator 
for poor patient outcome (Lange et al., 2012). It has been shown in melanoma, 
lymphoma and SCC (non melanoma skin cancer) that the expression of TKTL1 is 
increased compared to controls (Lange et al., 2012) and in the SCC (non melanoma 
skin cancer), TKTL1 over expression significantly correlates with tumor thickness and 
the mitotic rate (Lange et al., 2012). Furthermore, inhibition of TKTL1 decreases 
proliferation in the tumor cell (Du et al., 2004; Yuen et al., 2010). Expression of 
TKTL1 protein and glucose transporter 1 (GLUT1) both together was shown to be 
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indicative for a poor patient outcome in oral SCC (non melanoma skin cancer) 
(Grimm et al., 2014).  
 
 
 
                         
 
                                                                                                            (Hamanaka and Chandel, 2012) 
 Figure 6. Glycolysis and pentose phosphate pathway.                
 
 
3. Invasion of melanoma cells 
Another important step in melanomagenesis is invasion, which requires specific 
proteases to invade adjacent tissue (figure 2). 
 
3.1 Matrix metalloproteinases 
Matrix metalloproteinases (MMPs) are zinc dependent endopeptidases and a most 
prominent family of extracellular proteinases (Gross and Lapiere, 1962). 
Humans are expressing different types of MMPs in an enzymatically inactive state, 
which are called proenzymes. When these substrates convert into an active 
proteolytic enzyme, they are capable to degrade all kinds of extracellular matrix 
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proteins (Sternlicht and Werb, 2001). MMPs can be inhibited endogenously by tissue 
inhibitor of metalloproteinases (TIMPs). 
MMPs are playing a role in several physiological process, like cell proliferation, 
differentiation, angiogenesis, migration and apoptosis (Egeblad and Werb, 2002; 
Page-McCaw et al., 2007; Kessenbroc et al., 2011). 
In tumorigenesis, MMPs are an outstanding family of proteinases and changes in 
protolysis homeostasis are important for tissue invasion and metastasis (Liotta et al., 
1980). 
In vivo MMP activity can be detected by using a radiolabel inhibitor of MMP like 18F-
MMP and 123I-MMP inhibitors by PET and SPECT, that accumulates in the tumor 
(Furumoto et al., 2003; Schafers et al., 2004).  
Several investigations have shown in humans, that MMPs are expressed in the tumor 
and the tumor-associated stromal tissue in different carcinomas (Löffek et al., 2005) 
and increased level of activated MMP2 is associated with malignant progression in 
brain tumours (Yamamoto et al., 1996), lung tumor (Tokuraku et al., 1995), gastric 
carcinomas (Nomura et al, 1995) and in melanoma (Hoffman et al., 1999; Redondo 
et al., 2005). Furthermore, previous studies strongly implicate an important role of 
activated MMP2 in melanoma progression. 
Studies on MMP1 expression also showed that it could be expressed by tumor 
periphery in advanced melanomas (Airola et al., 1999). 
UV irradiation induces over expression of MMP1 and MMP10 in a SCC (non 
melanoma skin cancer) (Ramos et al., 2005). UV irradiation promotes melanoma 
progression through MMP9 activation (Shellman et al., 2006) and by MMP9-siRNA 
treatment, migration and invasion are significantly inhibited both in in vitro and in vivo 
(Tang et al., 2013). 
 
3.2 Urokinase plasminogen activator   
Urokinase plasminogen activator (uPA) is another protease, which is involved in 
thrombolysis and the degradation of extracellular matrix proteins. It has been shown 
that the over expression of urokinase, correlates with tumor malignancy, as it 
facilitates invasion and the process of metastasis (Keleg S et al., 2003).  
Particularly, it was shown that uPA and MMP9 are activated in IFNgamma/TNFalpha-
stimulated cells during invasion of melanoma cells (Bianchini et al., 2006). 
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4. Cell signaling and metabolism in melanoma  
Signal transduction pathways are necessary in normal cellular processes to transfer 
signals between extracellular and intracellular cell stimuli, which are most often 
achieved by protein kinases and its transcription factors. In cancer cells signal 
transduction pathways are often deregulated (Giancotti FG, 2014). Deregulation in 
signaling pathways is important for understanding melanoma development and 
progression. 
One of the major environment factors, which can trigger development of melanoma, 
is UV radiation, by inducing genetic and epigenetic alterations (Katiyar SK et al., 
2012). 
Major signaling pathways, which are involved in human melanoma pathogenesis, are   
MAPK/ERK (mitogen activated protein kinases/extracellular signal regulated kinases) 
and PI3K/AKT/mTOR (phosphoinositide 3 kinase/AKT/mammalian target of 
rapamycin) pathways, which promote proliferation, survival, angiogenesis and 
invasion of melanoma (Yajima et al., 2012), these pathways will be explained in 
detail in (figure 7).                    
 
                                                                                                                         
                                                                                                                              (Yajima et al., 2012) 
                       
Figure 7. Melanoma signaling pathway affects development and progression. 
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4.1 MAPK pathway in melanoma 
A common pathway which is activated during melanoma progression is the MAPK 
pathway (Goodall J, 2004), this pathway is usually activated through receptor 
tyrosine kinases (RTK) and then the signal is transferred to RAS proteins, like HRAS, 
KRAS, and NRAS, which then activate RAF proteins, like ARAF, BRAF and CRAF, 
subsequently activating MEK and ERK proteins and finally resulting in activation of 
transcription in the nucleus (figure 7). 
Deregulation or permanent activation of the MAPK pathway plays an important role in 
tumorigenesis of multiple human cancers such as prostate, breast, bladder, lung 
cancer, as well as melanoma (Inamdar et al., 2010). High mutation rates of MAPK 
pathway genes have been reported for the NRAS, BRAF and ERK genes and 
mutation rates for these genes are about 15-30%, 50-70% and 90% in human cancer 
(Davies et al., 2002; Cohen et al., 2002). 
 
4.2 PI3K pathway in melanoma 
Another signaling cascade of malignant melanoma, which is implicated in initiation, 
proliferation, progression and invasion via induction of cell survival cascades and 
inhibition of apoptosis cascades, is PI3K/AKT/mTOR signaling (Bunney and Katan, 
2010; Majewski et al., 2004). When PI3K protein is activated, it phosphorylates Akt 
protein kinase, which leads to the activation of Akt and mTOR. Interestingly, Akt 
phosphorylation at serine 473 is present in the majority of immunohistologically-
investigated melanomas (Dhawan et al., 2002) (Baban et al., in press) and activation 
of Akt is dramatically increased with melanoma progression (Dai et al., 2005) (figure 
7). It was shown, that over activation of AKT may be able to transform radial growth 
melanoma (RGP) to vertical growth melanoma (VGP) and thus, an overexpression of 
Akt increases the production of ROS and induces more glycolytic metabolism 
(Govindarajan et al., 2007).  
Additionally, it has been shown that increased glycolysis and overexpression of 
TKTL1 is associated with the activation of Akt (Volker et al., 2008) (Baban et al., in 
press). 
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4.3 UVA irradiation induces cell signaling 
UV radiation is able to induce many cell signaling pathways and most of these 
pathways are involved in induction of skin carcinogenesis, originating at cytoplasmic 
membrane receptors (Zhang et al., 2001), such as epidermal growth factor receptor 
(EGFR). UVA for example, is able to induce tyrosine phosphorylation of EGFR 
without ligand binding (dependant or independent) but it depends on the type of UV 
and the subsequent dose (Kneble et al., 1996).  
It has been shown, that an EGFR overexpression correlates with tumor progression  
(Correia et al., 2014) in many tumors, especially in head and neck, ovarian, cervical, 
bladder and oesophageal cancers (Nicholson et al., 2001). Furthermore, several 
chemotherapeutic treatments, that are targeting EGFR tyrosine kinase, are used 
clinically to decrease cancer proliferation, invasion and metastasis by tyrosine kinase 
inhibitors (Noonberg and Benz, 2001). 
After EGFR activation upon UVA irradiation, the signal is transferred to downstream 
ribosomal protein S6 kinases, p70 (S6K) and p90 (RSK) via PI3K and ERKs and 
EGFR(-/-) cells have the same effect like the one achieved with tyrosine kinase 
inhibitors (AG1478 and PD153035) (Zhang et al., 2001). 
 
4.4 Hypoxia-inducible factor 1 upregulation in melanoma 
The Hypoxia-inducible factor 1 alpha (HIF1α) is a transcription factor that mediates 
transcriptional responses upon hypoxia by activating the transcription of different 
target genes, which are associated with glycolysis and have a role in various cellular 
processes in a hypoxic microenvironment (figure 8) (Demaria et al., 2010). 
The overexpression of hypoxia-inducible factor 1 (HIF1) in many tumors, such as 
head and neck cancer, cervical cancer and renal cell carcinoma induced by hypoxia, 
is associated with tumor progression (Kuphal et al., 2010). In contrast to other 
tumors, it has been shown that in malignant melanoma even in normoxic condition, 
HIF1 activity is increased, due to constitutive HIF1α activation that is regulated by 
ROS (Kuphal et al., 2010). 
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                                                                                          (modified from Demaria et al., figure 8, 2010) 
Figure 8. HIF1α influence on the transcription of different genes. 
                                                                            
ROS, which can occur from damage or deregulation of mitochondria in hypoxic 
condition (Comito et al., 2011) and upon UV radiation in normoxic condition is able to 
upregulate HIF1α protein (Gidanian et al., 2008).  
Activation of HIF1 is important for cancer development and progression, meanwhile 
data have shown, that treating melanoma cells with an antioxidant (ROS quencher) 
was able to decrease HIF1α protein expression and HIF1 activity (Kuphal et al., 
2010). Inactivation of HIF1α leads to the reduction of pyruvate dehydrogenase kinase 
3 (PDK3) expression, which induces transport of pyruvate to the mitochondria.  
Subsequently, melanoma metabolism drives toward oxidative phosphorylation, 
instead of aerobic glycolysis and thus, glycolysis rate decreases (Kluza et al., 2012) 
(figure 8). 
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4.5 Poly ADP ribose polymerase 1 
Poly ADP ribose polymerase 1 (PARP1) or NAD+ ADP- ribosyl transferase 1 is an 
enzyme which has a role in DNA damage signaling, in mediating basal excision 
repair and DNA strand break repair (Godon C et al., 2008). Furthermore, it is 
important for differentiation, proliferation and tumor transformation (Rojo et al., 2012; 
Wang et al., 2015). For PARP synthesis, NAD+ is required as substrate and during 
PARP overactivation cells require more NAD+, subsequently inducing a progressive 
ATP depletion. PARP activation can be induced in ssDNA damage, like upon 
exposure to radiation (figure 9).  
Overexpression of PARP1 is associated with cutaneous malignant melanoma 
progression, since it is highly expressed in advanced stage of melanoma and 
correlates with melanoma thickness (Csete et al., 2008; Staibano et al., 2005). 
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                                                                                       (Modified from Huang and Shen figure 2., 2009) 
 Figure 9. PARP1 overactivation under the condition of oxidative stress increases ATP 
consumption. 
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5. Purpose of this work 
Previous literature showed that UVA radiation has physiologic relevance and is 
capable to induce melanoma in animals. The role of UVA radiation in melanoma 
progression in humans is not clear, thus the aim of our project was to investigate: 
 
5.1 Role of UVA irradiation in melanoma metabolism and progression 
It remains unclear if UVA radiation of initial melanoma is able to induce progression 
of melanoma cells. To investigate this, we irradiated cell lines of initial melanomas 
(IM) and metastasizing melanomas (MM) with chronic sublethal doses of UVA. The 
effect of UVA irradiation on glucose consumption, lactate production, different 
metabolites, transketolase activity, Akt expression, MMP and uPA transcriptional 
activity and invasive potential were determined. 
We investigated UVA dependent influence in glucose uptake and in lactate 
production, which was partially mediated by UVA induced ROS. This UVA induced 
and ROS mediated enhanced lactate production leads to the change of MMPs and 
uPA transcription and finally it influenced invasiveness of the UVA treated melanoma 
cells, which was shown in in vitro invasion assay and in skin reconstructs. 
Additionally, we analyzed the influence of UVA on different metabolic pathways, like 
pentose phosphate pathway, TCA cycle, and lipid metabolism because most of the 
proliferating tumor like melanoma have a metabolic demand for progression. This 
work was done in vitro, in melanoma cells, together with a cooperation partner, 
specialized on investigation of metabolites with NMR spectroscopy (Prof Gronwald, 
University of Regensburg).  
To interfere with UVA induced metabolic changes and to investigate the mediators of 
the persistence of these effects, it is important to identify cellular signaling cascades, 
which facilitate UVA induced Warburg effect as a potential target for anticancer 
therapies. As it is known, that UV irradiation has an effect on EGFR and IGFR 
signaling we started to investigate EGFR and IGFR signaling. First results showed 
change in the internalization rate of EGFR and IGFR upon UVA irradiation, compared 
to unirradiated samples, pointing to an UVA effect on these two receptors. 
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5.2 Role of mtDNA mutations in progression and invasion of melanoma cells 
Mitochondria play a pivotal role in metabolism and their role in carcinogenesis in the 
context of the Warburg effect is of actual interest. Although the need for 
mitochondrial ATP generation could be decreased in tumor cells, mitochondrial 
metabolism is still needed for anabolic processes like amino acid synthesis (Wallace 
et al., 2005). We found, that UVA radiation induces Warburg effect but on the other 
hand has mutagenic effects on mtDNA in human keratinocytes and fibroblasts 
(Berneburg et al., 1999). If these deletions accumulate, they can disturb the 
mitochondrial metabolism. UVA radiation is known to induce large scale deletions in 
mtDNA, the so called common deletion, which are considered as marker deletions for 
UVA exposure.  
To investigate the role of mtDNA 4977bp deletions and UVA exposure in human 
melanoma, the level of common deletion of melanoma tissue and control epidermal 
tissue from the same patient was analyzed from microdissected histological samples 
in cooperation with Prof. Röcken (Department of Dermatology, University of 
Tuebingen) and Prof. Seeger (Department of Gynecology, University of Tuebingen). 
We found that, the normalized level of mtDNA 4977bp deletion is different in normal 
nevi, dysplastic nevi and during progression of melanoma. These findings support 
the importance of functional mtDNA during carcinogenesis. Interestingly, the 
alteration of mtDNA 4977bp deletion level during carcinogenesis points to possible 
selection mechanisms during these process. 
 
 
 
 
 
 
 
 
 
  ! !!!!!32! !! !
32 C. Material and methods 
C. Material and methods 
1. Material 
1.1 Devices 
 
Devices 
 
Model 
 
        Company 
Centrifuge  Biofuge pico; Biofuge fresco/ 
Heraeus, Multifuge 3S-R 
Thermo Waltham/ 
Dreieich, Hanau 
Clean bench  Hera Safe KS 18  Heraeus, Frotscher 
Electrophoresis chamber Power Pac Basic, Power Pac 300 BioRad, Munich 
ELISA reader  Multiscan Ex Thermo, Waltham 
FACS  BD FACS Calibur  BD bioscience, Heidelberg 
FACS sorter  BD FACS Aria-cell sorter BD bioscience, Heidelberg 
Fluorescence reader  Tristar LB 941 Berthold technology, Bad 
Wildbad 
Gel-documentation,  
UV transilluminator 
RH-5.1 darkroom hood, easy 442K 
camera  
Herolab, Wiesloch 
Gel-electrophoresis 
apparatus 
Protean II, modell 45-2020i  BioRad, Munich 
Heating block mixer  Thermomixer comfort LS2  LS2 Eppendorf, Hamburg 
Incubator  Heracell 240 Thermal/Kendro 
 Dreieich/Hanau 
Laser capture 
microdissection 
apparatus 
Pix Cell IIe  Arcturus engineering Inc.; 
Mountain view, California 
 
Microscope  Axiovert25 Invers, Axiovert200 
fluorescence, HBO100  
Zeiss, Jena 
PCR-Machine  Primus 96 plus  MWG Biotech, Ebersberg 
pH-meter  CG842  Schott, Wertheim 
Photometer  Bio photometer 6131  Eppendorf, Hamburg 
Pipet aid  Pipette boy  Hirschman, Eberstadt 
Pipettes  Research, Reference  Eppendorf, Hamburg 
Real time PCR machine 
 
Light Cycler®480/iCycler Roche, Mannheim/ 
BioRad, Munich 
Rotary table KDE 015 MTE, Weinstadt-Endersbach/ 
UKT, Tuebingen 
Sonifier Sonoplus HD2070 Bandelin, Berlin 
Wb transfer system Trans blot turbo BioRad, Munich 
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UVA lamp  Sellasol 1200  Sellas, Gevelsberg 
Vortexer Reax top  Heidolph, Kelheim 
Water bath WB22 funke  Medingen, Freital 
X-ray film processor Optima mammo X-ray film processor Rontgen Bender 
 
Table 2. Device manufacturer. 
 
1.2 Kits 
 
Kits 
 
Company 
BCA protein assay Pierce, Rockford 
GO glucose assay Sigma, Deisenhofer 
iScript cDNA synthesis BioRad, Munich 
Lactate reagent Trinity biotech, Wicklow 
Novex zymogram gelatine gel  Life technologies, Darmstadt 
Nucleospin RNA II  Macherey-nagel, Duren 
QIAamp DNA-mini  Qiagen, Hilden 
QCM TM Matrix 24 well invasion assay  Millipore, Billerica 
Sso Fast EvaGreen Supermix BioRad, Munich 
uPA ELISA kit antibody Abcam, Cambridge 
                    
Table 3. Used kits with it source. 
 
1.3 Antibodies 
 
Antibodies 
 
Catalog 
number 
 
Manufacture 
Anti glucose transporter GLUT1           ab652 Abcam, Cambridge 
Anti MMP9 antibody           ab38898 Abcam, Cambridge 
Anti urokinase antibody          ab24121 Abcam, Cambridge 
APC anti human EGFR          352905 Biolegend, San Diego 
β actin (8H10D10) mouse mAb           3700S Cell signalling technology 
GAPDH (14C10)          2118 Cell signalling technology 
pADPr (10)          sc-56198 Santa cruz biotechnology 
Phospho Akt (Ser473)           9271 Cell signalling technology 
Phospho EGF receptor          3777 Cell signalling technology 
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Purified mouse anti-human HIF1α          610958 BD bioscience, Heidelberg 
Anti S100 antibody Z0311 Dako, Germany 
 
Table 4. Primary antibodies used for western blot and FACS. 
 
1.4 Primer 
1.4.1 DNA repair gene primer  
 
Primer 
  Annealing 
temperature 
°C 
 
Sequence 
 
Company 
ATM 46 AAGTGAAAACTTATTGGGAAAACAG 
TTGCTGGCTCATGTAACGTC  
Biomers 
ATR 51 CGCTGAACTGTACGTGGAAA 
CAATTAGTGCCTGGTGAACATC 
Biomers 
BAX 60 CATGGAGCTGCAGAGGATGAT 
TTGCCGTCAGAAAACATGTCA 
Eurofins 
MWG Operon 
BCL2 60 GGCTGGGATGCCTTTGTG 
GCCAGGAGAAATCAAACAGAGG 
Eurofins 
MWG Operon 
BRCA1 52 ATCATTCACCCTTGGCACA 
CATGGAAGCCATTGTCCTCT 
Biomers 
BRCA2 52 ACATGCCCACAGGGTGTC 
CACATCTGCCCAATTGCAT 
Biomers 
ERCC1 50 GAAATTTGTGATCCCCTCGAC 
GATCGGAATAAGGGCTTGG 
Biomers 
CHK2 52 AAGCCAGAGAATGTTTTACTGTCA 
CTTGGAGTGCCCAAAATCAG 
Biomers 
HR23A 
 
50 GTCACCATCACGCTCAAAAC 
CTTCTCCTTTAGCACCTTCACC 
Biomers 
HR23B 
 
50 GCAGCAACTACGACAGCAAC 
CTGAGGCTGATTCCGTAAAAA 
Biomers 
MDM2 
 
52 CCATGATCTACAGGAACTTGGTAGTA 
TCACTCACAGATGTACCTGAGTCC 
Biomers 
P21 52 TCACTGTCTTGTACCCTTGTGC 
GGCGTTTGGAGTGGTAGAAA 
Biomers 
P53 
 
60 CCCAGCCAAAGAAGAAACCA 
GTTCCAAGGCCTCATTCAGCT 
Eurofins 
MWGOperon 
PARP1 54 CTTGCTGCTTGTTGAAGAT 
AGGCTGCTTTGTCAAGAA 
Biomers 
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XPA 46 GACACAGGAGGAGGCTTCATT 
TCGCATATTACATAATCAAATTCCATA 
Biomers 
XPB 
 
50 ACTGGATGGAGCTGCAGAAT 
GGAGACATAGGGCACCAGAC 
Biomers 
XPC 
 
60 GCCGAGACCTTGAGACCATA 
TCCATGTGTTTTGCCTGAAA 
Biomers 
XPD 
 
50 TTGAGACCCGGGAGGATATT 
ATGCCATCAGGGACCACA 
Biomers 
XPE 50 CCCCTCAATTCAGATGGCTA 
GGTGAGGGTGCTATTGTTGG 
Biomers 
XPF 
 
50 GAGGCAGAAAATGAGAGTGAA 
CATGTTCGGTCATCACTTGC 
Biomers 
XPG 50 CCAAGCGCAGAAGAACATTA 
TTAAGCAAGCCTTTGAGTTGG 
Biomers 
 
Table 5. Primer used for DNA repair gene analysis. 
 
1.4.2 Protease gene primer 
 
Primer  
  Annealing 
temperature 
°C 
 
Sequence 
 
Company 
MMP1 54 CACCAAGGACAAGCACAG 
ACACAGTAGGCCAGGTCTCG  
Biomers 
MMP2 54 CCCCAAAACGGACAAAGAG 
CTTCAGCACAAACAGGTTGC 
Biomers 
MMP3 54 CAAAACATATTTCTTTGTAGAGAGGACAA 
TTCAGCTATTTGCTTGGGGAAA 
Eurofins 
MWGOperon 
MMP9 54 GAACCAATCTCACCGACAGG 
GCCACCCGAGTGTAACCATA 
Biomers 
MMP13 54 CCAGTCTCCGAGGAGAAACA 
AAAAACAGCTCCGCCGCATCAAC 
Biomers 
MMP15 54 ACGGTCGTTTTGTCTTTTCA 
GTCAGCGGCTGTGGGTAG 
Biomers 
TIMP1 54 TGGATAAACAGGGAAACACTG 
GATGGACTCTTGCACATCAT 
Biomers 
uPA 54 TTGCTCACCACAACGACATT 
GGCAGGCAGATGGTCTGTAT 
Biomers 
Table 6. Primer used for protease gene analysis.                                           (Baban et al., in press) 
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1.4.3 mtDNA common deletion and HIF1α primer 
 
Primer 
(gene 
expression) 
 
Annealing 
temperature 
°C 
 
Sequence 
 
Company 
CD 54 ACC CCC ATA CTC CTT ACA CTA TTC  
AAG GTA TTC CTG CTA ATG CTA GGC  
Biomers 
HIF1α 54 GTTTACTAAAGGACAAGTCACC 
CTCCCTTCAACAAACAGAA 
Biomers 
 
Table 7. Common deletion and HIF1α primer. 
 
1.4.4 House keeping gene primer 
 
Primer  
  Annealing 
temperature 
°C  
 
Sequence 
 
Company 
β actin 46-60 GCACCCAGCACAATGAAGA 
CGATCCACACGGAGTACTTG 
Biomers 
GAPDH 46-60 CACCAAGGACCAAGCAGACAG 
ACACAGTAGGCCAGGTCTCG 
Biomers 
IS 54 GAT TTG GGT ACC ACC CAA GTA T 
AAT ATT CAT GGT GGC TGG CAG TA 
Biomers 
 
Table 8. Primer used as house keeping genes. 
 
1.5 List of Human melanoma cell lines 
 
Cell line 
 
Growth phase of 
melanoma 
 
Abb. 
 
              Source 
WM 35 Initial growth phase, 
radial growth phase 
IM Prof. Schittek, Department 
of Dermatology, Tuebingen 
WM 1552c Initial growth phase, 
radial growth phase 
IM Zentrum für Medizinische 
Forschung (ZMF),Tuebingen 
WM 3211 Initial growth phase, 
radial growth phase 
IM Zentrum für Medizinische 
Forschung (ZMF),Tuebingen 
Sbcl2 Initial growth phase, IM Prof. Schittek, Department 
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radial growth phase of Dermatology, Tuebingen 
WM 115 Initial growth phase, 
vertical growth phase 
IM Prof. David Melton, Cancer 
research center, Edinburgh 
WM 793 Initial growth phase, 
vertical growth phase 
IM Prof. Schittek, Department 
of Dermatology, Tuebingen 
BLM Advanced growth phase, 
metastasizing melanoma 
MM Prof. Schittek, Department 
of Dermatology, Tuebingen 
WM 1205 Advanced growth phase, 
metastasizing melanoma 
MM Prof. Schittek, Department 
of Dermatology, Tuebingen 
WM  
451 LU 
Advanced growth phase, 
metastasizing melanoma 
MM Prof. Schittek, Department 
of Dermatology, Tuebingen 
WM 266-4 Advanced growth phase, 
metastasizing melanoma 
MM Prof. Bauer, Department of 
Dermatology, Tuebingen 
                                                                                               (Baban et al., in press) 
Table 9. Human melanoma cell lines. 
 
1.6 Chemicals 
 
Chemical  
 
Source 
Acrylamide / Bisacrylamide (30% / 0.8%)  Roth, Karlsruhe 
Agarose  Roth, Karlsruhe 
Amiroride Santa cruz biotechnology 
Antibiotic-antimycotic solution PAA, Pasching 
Anthelios XL, LSF 50+, spray La Roche-posay, Asnieres-
Cedex 
Bovine serum albumin Sigma, Deisenhofen 
Calcium chloride Sigma, Deisenhofen 
3-Cholamidopropyl-dimethylammonio-1-propansulfonate 
(CHAPS)  
Sigma, Deisenhofen 
2-Deoxy-D glucose Sigma, Deisenhofen 
D (-) Mannitol  Roth, Karlsruhe 
Dntp Set, PCR grade  Qiagen, Hilden 
Diglycine (Gly – Gly)  Fluka, Buchs 
Dimethylsulfoxide (DMSO) Sigma, Deisenhofen 
Disodium hydrogen phosphate (Na2HPO4) Fluka, Buchs 
Dithionite Fluka, Buchs 
DPBS Life technologies, Darmstadt 
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Dulbecco’s phosphate buffered saline 1x (PBS) PAA, Pasching 
Sigma, Steinheim 
Dulbecco’s modified eagle medium (DMEM), 1 g/l and 4.5 
g/l glucose with glutamine 
PAA, Pasching 
Sigma, Steinheim  
Eosin y solution Merck, Darmstadt 
Ethanol 100% Merck, Darmstadt 
Ethylene diamine tetraacetic acid (EDTA) Roth, Karlsruhe 
Fetal bovine serum (FBS) Thermo science, Waltham 
Formaldehyde Roth, Karlsruhe 
Formalin Roth, Karlsruhe 
GelRed Biotium, Hayward 
Glycine Roth, Karlsruhe 
GM 6001 Santa cruz biotechnology 
Marker 100bp plus DNA-leiter Fermentas, St. Leon Rot 
HBSS  Life technologies, Darmstadt 
Haematoxylin Dako, United State 
Horseradish peroxidase (HRP) Life technologies, Darmstadt 
H2O nuclease free Qiagen, Hilden 
Hydrochloric acid (HCl) Sigma, Deisenhofen 
Hydrogen peroxide (H2O2) Roth, Karlsruhe 
Potassium chloride (KCl)  Roth, Karlsruhe 
Potassium dihydrogen phosphate (KH2PO4) Roth, Karlsruhe 
Potassium hydroxide (KOH) Sigma, Deisenhofen 
Protease inhibiter tablet Roth, Karlsruhe 
L (+) Lactic acid Roth, Karlsruhe 
Lithium-hydroxypyruvat Roth, Karlsruhe 
Magnesium chloride (MgCl2) Fluka, Buchs 
Methanol  VWR, Darmstadt 
Milk powder DM, Karlsruhe 
Novex sharp pre-stained protein standard  Life technologies, Darmstadt 
Sodium carbonate (Na2CO3) Roth, Karlsruhe 
Sodium chloride (NaCl) Merck, Darmstadt 
Sodium dichloroacetate Sigma, Deisenhofen 
Sodium fluoride  Roth, Karlsruhe 
Sodium hydrogen phosphate (Na2HPO3)  Sigma, Deisenhofen 
Sodium hydroxide  Merck, Darmstadt 
Sodium phosphate Sigma, Deisenhofen 
Sodium dodecyl sulphate (SDS) Fluka, Buchs 
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Paraformaldehyde Sigma, Deisenhofen 
PCR buffer 10x  Qiagen, Hilden 
Phenylmethanesulfonyl fluoride (PMSF) Sigma, Deisenhofen 
Propanol Merck, Darmstadt 
Propionaldehyde Fluka, Buchs 
Tetraalkylammonium carbonate Sigma, Deisenhofen 
Streptomycin / Amphotericin B PAA, Pasching 
Thiaminepyrophosphate Sigma, Deisenhofen 
Thiazolyl blue tetrazolium bromide (MTT) Sigma, Deisenhofen 
Triphenyltetrazoliumchloride Sigma, Deisenhofen 
Tris Sigma, Deisenhofen 
Tris glycine SDS Invitrogen, Darmstadt 
Triton 100X Roth, Karlsruhe 
Trolox 
(6Hydroxy-2,5,7,8 tetramethylchromane-2-carboxylic acid) 
Sigma, Deisenhofen 
Trypanblue Biochrom, Berlin 
Trypsin EDTA 0,5% Gibco, United state 
TweenR 20 Roth, Karlsruhe 
Ultra low range DNA ladder I  PeqLab, Erlangen 
Vitamin B1 (Thiamine) Sigma, Deisenhofen 
Zink chloride Sigma, Deisenhofen 
 
Table 10. List of chemicals used during experiments. 
 
1.7 Materials  
 
Material 
 
Company 
Adhesive clear qPCR seals sheets 
 
Biozym, Hessisch Oldendorf 
Capsure marcoLCM caps Life technologies 
 
Life technologies, Darmstadt 
 Cell culture flasks Greiner, Frickenhausen 
 Capillary tips Biozym, Hessisch Oldendorf 
 Cryo tubes Greiner, Frickenhausen 
 Cuvettes Ratiolab GmbH, Dreieich-
Buchschlag 
 Glassware Schott AG, Mainz 
 Falcons Greiner, Frickenhausen 
 Filter tips Greiner, Frickenhausen 
 Freezing container “Mr Frosty“ Thermo science, Waltham 
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Table 11. List of material and plastic goods used during experiments. 
 
 
1.8 Buffer 
1.8.1 Cell Culture medium 
• Cell Culture medium for melanoma cells: 
                                                       89   %    DMEM      
                                              10   %    FCS 
                                                1   %    Streptomycin / Amphotericin B  
• Cell Culture medium for fibroblast cells: 
                                                  89   %    MEM      
                                              10   %    FCS 
                                                1   %    Streptomycin / Amphotericin B  
• Cell Culture freezing medium for melanoma cells: 
                                              30   %   DMEM      
                                              60   %   FCS 
                                              10   %   DMSO      
! Sterile filtered FCS solution was aliquoted and stored at -20 °C for several 
months.  
 
 
 Neubauer cell counting chamber Hecht, Sondheim/ Rhon 
 PCR reaction eppendorfs  Biozym, Hessisch Oldendorf 
 Petri dishes Greiner, Frickenhausen 
 Plastic container for centrifuges BD bioscience, Heidelberg 
 Plastic pipettes Costar, Fernwald 
 PVDF transfer membranes hybond GE-Healthcare, Freiburg 
 Reaction eppendorfs (1ml) Eppendorf, Hamburg 
 Slides superfrost /plus R.Langenbrink, Emmendingen 
 Sterile filter (0,22 µm) Millipore, Billerica 
 Syringes Greiner, Frickenhausen 
96 well-PCR plates Peqlab, Erlangen 
Well plates Greiner, Frickenhausen 
Whatman paper GE-Healthcare, Freiburg 
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1.8.2 Gel electrophoresis (agarose) buffers 
• TAE buffer: 
                                          2  mM   EDTA 
                                          1  mM   NaAc 
                                        40  mM   Tris HCl 
                                                       pH 8.0 
• Loading buffer:                                 
                                        0.2   %    Bromphenol blau 
                                         50   %    Glycerine 
                                         50   %    TAE-buffer 
• 2% agarose gel:  
 2% agarose (w/v) prepared with the appropriate amount of 1x TAE buffer.  
 
• 5% agarose gel:  
5% agarose (w/v) prepared with the appropriate amount of 1x TAE buffer. 
 
1.8.3 Transketolase buffer and reaction solution  
• Lysis buffer:  
                                     0.5   mM    Benzamidine 
                                      40   mM    Citrate 
                                      40   mM    Sodium phosphate 
                                   0.25   mM    Phenylmethanesulfonyl fluoride (PMSF) 
                                                            pH 6 
• Reaction solution:                                           
                                    360     µl    Gly-Gly (50 mM) 
                                    120     µl    Lithium hydroxypyruvat (250 mM) 
                                      60     µl    MgCl2 (90 mM) 
                                      60     µl   Thiamine pyruphosphat (24 mM) 
                                      10     µl   177 ng/ml Thiamine 
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1.8.4 Western blot buffers 
• Lysis buffer: 
                                    150   mM   Sodium chloride 
                                        1    %     Nonidet P-40 
                                     0.5    %     Sodium deoxycholate 
                                     0.1    %     Sodium dodecyl sulphate (SDS) 
                                                      Protease inhibitors  
                                                      pH 7.4 
• 10x SDS-PAGE buffer: 
                                       2    M     Glycine 
                                       1    %     SDS 
                                   250   mM   Tris  
                                                      bidest  H2O 
                                                      pH 8.3 - 8.5  
• WB semidry buffer: 
                                    0.2    M      Glycine  
                                     20    %      Methanol  
                                     25   mM    Tris                       
                                                      bidest  H2O 
                                                      pH 8.5  
 
• 10x TBS (Tris buffered saline): 
                                      8    %       NaCl                                
                                  200    mM    Tris  
                                   bidest  H2O          
                                                       pH 7.6           
 
• TBS Tween 20 (TBST): 
  0.1% Tween 20 in 1x TBS. 
 
• Blocking buffer: 
   5% non-fat dry milk or bovine serum albumin (BSA) in TBST. 
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2. Methods 
2.1 Cell culture  
2.1.1 Cell culture maintenance 
Human melanoma cells of the different progression levels from vertical growth phase 
(VGP), radial growth phase (RGP) and metastasizing melanoma (MM) (table 9) for 
cultivation and progression were cultured in cell culture flasks with DMEM medium, 
complemented with 10% FCS and 1% antibiotic-antimycotic solution 
(streptomycin/amphotericin B) at 37°C in a humidified atmosphere enriched with 5% 
CO2 in an incubator (Baban et al., in press). Melanoma cells are adherently growing 
cells and every 2-3 days the medium was renewed.  
For splitting, when the flask is a proximally 80% confluent, cells were washed with 
PBS X1 then treated with 3ml of the pre-warmed trypsin solution for 5 min to detach 
cells, for stopping trypsin reaction, 3-5ml of DMEM medium, complemented with 10% 
FCS was added, to inactivate proteolysis effect of trypsin. After transferring the 
required volume of cell suspension into new flasks, each flask was filled with DMEM 
and the flasks were placed in the incubator to allow cells to settle down and attach 
again. 
 
2.1.2 Cryopreservation 
When the cells in the flasks reached confluence, cells were detached, using trypsin 
as described before and reaction was inhibited with complete DMEM. The cell 
suspension was centrifuged at 1500 rpm for 5 min. After discarding the supernatant, 
the precipitated pellet was resuspended in 1ml of freezing medium and cell 
suspension was transferred to freezing vials and stored in -80 °C for 24 hr. For long 
term storage cells were transferred to liquid nitrogen.  
For culturing cells, after thawing, they were immediately transferred to a tissue 
culture flask containing pre-warmed DMEM. Melanoma cells were cultivated in an 
incubator, all steps of thawing should be performed quickly. 
The day after thawing the cells, the medium of cell culture flasks was exchanged with 
fresh DMEM (1 g/l low glucose media).  
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2.1.3 Cell counting with Neubauer chamber 
The Neubauer chamber or hemocytometer is a device used to determine the number 
of cells per unit volume. The grid area in the counting chamber is divided into 9 large 
squares, each square has a surface area of 1 mm2 and depth of 0.1 mm after putting 
the glass cover over it. 
After cells were harvested, they were diluted and counted in a volume ratio of 1:1 
with trypanblue and pipetted and drawn by capillary force to grid area in a Neubauer 
chamber. A light microscope was used to count live cells in the counting fields. 
To calculate total cell number in absolute volume, all cells in 4 large squares were 
counted (by light microscope) then the average count was founded, which was 
multiplied by chamber factor 10 000 (cell/ml) and the dilution factor. To get the total 
cell number in a specific volume, the number was multiplied by total volume in ml: 
 
                 Cells per ml = average count x dilution factor x 10 000 
 Cells per total volume = average count x dilution factor x 10 000 x volume  
 
2.2 Determination of cell viability and proliferation by MTT assay 
Equivalent number of each melanoma cell line was irradiated with UVA radiation 
within different doses from 4 to 10 J/cm2 three times daily for 4 consecutive days. 
After UVA irradiation, melanoma cell lines were treated with tetrazolium dye MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), using a concentration of 
5 mg/ml and incubated at 37°C for 3.5 hr.  
Cells were treated 15 min with MTT solvent (4mmole HCl, 0.1 % nodent in 
isopropanol), cell viability and proliferation was measured, using ELISA reader at 
optical density of 590 nm.   
 
2.3.1 UVA irradiation  
Irradiation was carried out according to and as described (Berneburg et al., 2005; 
Kamenisch et al., 2010; Koch et al., 2001). Briefly, cells were irradiated with a UVA 
irradiation lamp with different doses from 4 to 10 J/cm2 of UVA three times daily for 4 
consecutive days (Baban et al., in press). 
For UVA irradiation experiment, equivalent number of each melanoma cell lines was 
seeded and cultivated in 10cm or 15cm diameter of adherent cell culture Petri dishes 
in DMEM with 4.5 g/l glucose (high glucose media). During irradiation DMEM was 
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replaced by PBS X1 and collected in a sterile Falcon to avoid chemical changes in 
the medium by UVA irradiation. Petri dishes were placed on a turntable to uniformly 
irradiate whole petri dishes, treatment was three times per day, with 4 hr intervals 
between irradiation coarse, to give cells enough time for entire recovery.  
Periodically, UVA emitted energy by UVA lamp was re-measured, which was 
necessary for calculating the exact exposure time for each dose. 
For each experiment and according to each cell line a control (without irradiation) 
was included.  
 
2.3.2 Chemical treatment during UVA irradiation  
Cells were treated with Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic 
acid) during the irradiation, with a dose of 20µM, which is similar to doses observed 
in plasma (20-100µl/l) after oral Trolox treatment. Cells were treated with 2-DG (2 
deoxy-D-glucose) during the irradiation, with doses of 10µM and 5.5mM, which are 
similar to 2-DG concentrations (1.76 mM) observed in the blood of patients with 2-DG 
treatment (Yamaguchi et al., 2011). Cells were treated 12 hr with lactic acid to induce 
MMPs and uPA transcription with a dose of 20mM, which is close to concentrations 
that are observed in the micromillieu of tumors (Serganova et al., 2011). For inhibition 
of uPA, amiloride (3,5-diamino-6-chloro-N-(diaminomethylene)pyrazine-2-
carboxamide) was used at doses of 7µM during irradiation and recovery and 0.1mM 
during invasion assay. For MMPs inhibition, GM6001 (N-[(2R)-2-
(Hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan methyl amide) was 
used at doses of 10nM during irradiation and recovery and 1µM during invasion 
assay (section from Baban et al., in press).  
 
2.4 Glucose measurement  
Glucose measurement was performed according to instruction of glucose go assay 
(sigma) in the cell culture supernatant. Glucose is oxidized by glucose oxidase 
reagent to gluconic acid and H2O2, o-dianisidine and peroxidase in the reagent reacts 
with H2O2 to produce a brown colored product (oxidized o-dianisidine), later on a 
stable pink colored product is formed by addition of 12N sulfuric acid H2SO4. 
The maximum absorption intensity of pink colored products was directly proportional 
to the total amount of glucose in the samples at 540 nm. 
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Procedure for glucose measurement 
1. After irradiation courses supernatant was collected immediately 
2. Dilution of cell culture media was done with bidest.H2O  
                           Low glucose medium (1g/l) was diluted 1:10 
                           High glucose medium (4.5g/l) was diluted 1:100 
           3.  Blank: 100µl diluted pure media 
           4.  Standard preparation: standard (1mg/ml) was diluted 1:20 with ddH2O  
           5.  Reaction steps were followed as described in manual of glucose go 
                protocol assay. 
 
Calculation 
Whole amount of glucose, which was consumed by cells in the supernatant, was 
calculated by the difference of glucose in beginning compared to the end of 
experiments. 
 
The glucose consumption [mg] = entire glucose [mg] – residual glucose [mg] 
 
The amount of glucose consumption in the supernatant [mg] was normalized to the 
number of cells [million cells] after irradiation courses. Throughout the experiment the 
same volume of media was used for all samples.  
For glucose measurement in skin reconstructs lysate, the skin reconstructs were 
weighted and immediately incubated in 50µl of PBS X1 at 95°C for 5 min. Glucose 
concentration was measured by using glucose go assay protocol, as described 
above. 
 
2.5 Lactate measurement by color enzymatic method  
Principle of enzymatic approach 
Lactate measurement was performed according to the protocol of the lactate kit 
(Trinity biotech), instruction for cell culture supernatant; lactate reagent contains 
oxidase, peroxidase enzymes and chromogen precursors to form a colored product.  
The maximum absorption intensity of colored products was directly proportional to 
the total amount of lactate in the samples at 540 nm. 
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Procedure for lactate measurement 
1. After irradiation courses supernatant was collected immediately 
2. Supernatant was mixed with lactate reagent in volume ratio of 1:100  
3. Blank: 100µl diluted pure media 
4. Standard preparation:   
     40 mg/dl standard was used in volume ratio of 1:100 
5. Rest of procedure was performed according to the lactate kits protocol. 
 
Calculation 
The amount of lactate produced by cells in the supernatant, as determined in [mg] 
was normalized to the number of cells [million cells] after irradiation courses. 
Throughout the experiment the same volume of media was used for all samples.  
For lactate production measurement in skin reconstructs, the skin reconstruct was 
weighted and immediately incubated in 50µl of PBS at 95°C for 5 min. Then, lactate 
concentration was measured by using lactate reagent assay Kit protocol (Baban et 
al., in press). 
 
2.6 Transketolase activity measurement 
Transketolase activity was measured colorimetrically. Briefly, after UVA irradiation, 
cells were harvested, pelleted and lysed by addition of transketolase lysis buffer. 45µl 
of mixture1 (120µl Li-HPA (250 mM), 60µl MgCl2 (90 mM), 60µl TPP (24 mM), 360µl 
Gly-Gly (50 mM), 10µl 177 ng/ml thiamine) was incubated with 45µl of cell lysate and 
20µl propionaldehyde. This reaction mix was incubated for 72 hr at RT. Afterward it 
was incubated with Gly-Gly (50 mM) and 10 mg tetraalkylammonium carbonate 
(polymer-bound carbonate resin beads) for 24 hr at RT, followed by treatment 
tetrazolium red (0.2% in methanol). This assay as described by (Smith et al., 2006), 
has been adapted and modified to the needs of the irradiation experiment. For 
transketolase activity measurement, the skin reconstructs were weighted and 
subsequently transketolase activity was measured calorimetrically as described 
above. Measurement was carried out at 492 nm optical density, using an ELISA 
reader (Baban et al., in press). 
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2.7 Nuclear magnetic resonance spectroscopy 
NMR spectroscopy is a research technique mostly used in biochemistry to determine 
the chemical properties of atoms and molecules by taking the advantage of magnetic 
properties of particular atomic nuclei.  
Equivalent numbers of different melanoma cell lines were irradiated with 6 J/cm2, 
three times daily for 4 consecutive days. After UVA irradiation course, melanoma 
cells were harvested and detached with ethanol by mechanical force, then 
supernatant and cells were stored at -80°C until sending to University of Regensburg 
for NMR analysis. 
UVA induced metabolic change was investigated, the uptake or secretion of different 
metabolomics such as amino acids in the supernatant and cell pellets of control and 
UVA irradiated melanoma cells, in cooperation with the University of Regensburg 
(Prof Gronwald) by NMR. 
Changes in metabolomics concentration in [µM] within the supernatant and 
melanoma pellets with and without UVA irradiation, were normalized to protein 
concentration. Data are presented as mean value with standard deviation of 3 
independent experiments. 
 
2.8 Fluorescence activated cell sorting 
Fluorescence activated cell sorting (FACS) is a biotechnical method used for sorting 
a heterogeneous population of living cells into two or more subpopulations, based on 
distinct fluorescent labeling of each cell type. 
The initial targets of UVA signaling in melanoma cells are Epidermal growth factor 
receptor (EGFR) and Insulin-like growth factor receptor (IGFR). To investigate the 
influences of UVA irradiation on both receptors, FACS analysis was performed. For 
that purpose, equivalent number of different melanoma cell lines were irradiated with 
6 J/cm2, three times daily for 4 consecutive days. After UVA irradiation course, 
melanoma cells were harvested and stained with EGFR antibody and IGFR antibody 
by incubating for 1 hr at 37°C. After the incubation period with antibodies, cells were 
centrifuged for 5 min at 1500 rpm and the pellet was washed twice with 10 ml PBS 
and resuspended in medium (MEM + 10% FCS). 
Indirectly, by detection of IGFR and EGFR on cellular surface with fluorescent-
labeled antibodies, the mean value of internalized EGFR and IGFR population was 
estimated. 
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 2.9 DNA isolation 
Instructional information and detailed manual of the QIAamp DNA micro kit from 
Qiagen protocols for molecular biology experiment was used to carry out DNA 
extraction in the laser micro dissection tissues. 
DNA genome purification was performed for human tissue sections, which were 
isolated by laser capture micro dissection microscope from paraffin embedded slices. 
Genomic DNA was used for of analysis mitochondrial common deletion gene 
expression by PCR (table 17 and 18). All steps were rapidly carried out after DNA 
isolation, as DNA is not stable. All steps were performed at room temperature. 
 
2.10 RNA isolation 
According to instructional information and detailed manual of the RNA NucleoSpin®II 
kit from Macherey-nagel, RNA genome purification from cell culture cells was 
performed. 
Cells were harvested, pelleted and then resuspended in 300 µl of lysis buffer 
contained in the kit. Subsequently RNA was eluted in 60µl RNAase free H2O. All 
procedure steps were carried out at RT. Measurement of RNA and DNA 
concentration and purification success was done with the spectrophotometer.  
2µl of RNA sample was diluted in 60µl double bidest.H2O and bidest.H2O was used 
as a blank for photometer calibration. A measurement of optical density or UV 
absorbance at 260 nm wavelengths for nucleic acid was used to determine nucleic 
acid concentration. The RNA and DNA concentration was calculated, using 
photometer software. Then, 2% agarose gel electrophoresis was done for verifying 
purification of RNA. 
 
2.11 cDNA Synthesis  
Complementary DNA (cDNA) is a double strand DNA, which was synthesized from 
messenger RNA (mRNA) template by reverse transcriptase enzyme during reverse 
transcription polymerase chain reaction (RT-PCR). The cDNA synthesis was 
synthesized according to iscript synthesis kit for cDNA synthesis (table 12 and 13).   
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Components 
 
Volume 
1. 5X iscript reaction mix                            4 µl 
2. Iscript reverse transcriptase  1 µl 
3. Nuclease free H2O                                 X µl 
4. RNA  (1µg)                                          X µl 
Total volume / reaction                       20µl                 
    
  Table 12. cDNA synthesis setup.             
                   
 
Phase 
 
Duration 
 
Temperature 
1  5 min 25 °C 
2             30 min 42 °C 
3  5 min 85 °C 
Hold  5 min  4  °C 
 
Table 13. cDNA synthesis protocol.      
 
2.12 Real time PCR  
Real time PCR is a method, used to amplify and quantify target DNA genetic 
molecules (Mats Nilsson, 2002; Thore Hillig, 2012; Kameisch et al., 2010). 
After cDNA synthesis by RT-PCR protocol (described in table 12 and 13), DNA 
quantification was determined with real time PCR protocol, by using EvaGreen 
Supermix and specific primer pairs (shown in table 6,7 and 8). Roche light cycler 
instrument was used in this study for analysis of expression level of different 
proteases and protein kinases that are involved in melanoma invasion and cell 
signaling pathways respectively. GAPDH and β actin were used as housekeeping 
genes that were chosen as they showed a stable expression. Additionally, internal 
standard (IS) primer (table 8) was used in real time PCR of mtDNA common deletion 
gene expression as housekeeper for relative relation to the total amount of mtDNA 
(described in table 14, 15, 16 and 17) (Koch et al., 2001). The amplification products 
of the target genes were normalized to the amplification products of the 
housekeeping genes. Delta Ct (ΔCt) was measured between target gene Ct and 
housekeeping gene Ct. Fold change or the value of difference of target gene 
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between (ΔCt) treated and (ΔCt) untreated were calculated as 2-Δ(ΔCt), which means 
the difference in the target gene between treated and control samples (Livak and 
Schmittgen, 2001). 
After real time PCR, 5% agarose gel electrophosis was performed for the 
amplification products to detect bands with the size of the gene product. 
 
 
Components 
 
Volume 
EvaGreen Supermix   12.5  µl 
Primer forward 0.025  µl 
Primer reverse 0.025  µl 
cDNA                              1  µl 
Nuclease free H2O                         11.5  µl 
Total volume / reaction                            25  µl 
 
Table 14. Real time PCR setup.  
  
 
Phase 
 
Temperature  
 
Duration 
Pre incubation 95 °C   5   min 
Amplification 95 °C 
54 °C 
72 °C 
10  sec 
10  sec 
10  sec 
Melting 95 °C 
65 °C 
95 °C 
10  sec 
              1  min 
Cooling 40 °C 10  sec 
 
Table 15. Real time PCR protocol for MMPs and uPA. 
 
 
Components 
 
Amount 
EvaGreen Supermix   12,5  µl 
Primer forward 0.125  µl 
Primer reverse 0.125  µl 
DNA 250 ng      X   µl 
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Nuclease free H2O      X   µl 
Total volume / reaction     25  µl 
 
Table 16. Real time PCR setup for mtDNA common deletion.  
 
 
 
Phase 
 
Temperature  
 
Duration 
Pre incubation 95 °C   5  min 
Amplification 95 °C 
58 °C 
72 °C 
10  sec 
10  sec 
10  sec 
Melting 95 °C 
65 °C 
95 °C 
             10  sec 
  1  min 
Cooling 40 °C  10  sec 
 
Table 17. Real time PCR protocol for mtDNA common deletion by light Cycler. 
 
Real time PCR protocol, which was used in experimental setup for MMPs and uPA 
gene expression, was used for other primers with annealing temperature adapted, 
according to each primer. 
 
 
Phase 
 
Temperature  
 
Duration 
Denaturation 95 °C 2  min 
Amplification 95 °C 
58 °C 
72 °C 
5  sec 
            10  sec 
5  sec 
Melting 65 °C             10  sec 
Cooling 15 °C               Hold  
 
Table 18. Real time PCR protocol for mtDNA common deletion by iCycler 
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2.13 Agarose gel electrophoresis 
Agarose gel electrophoresis is the most effective way for separation DNA fragments 
by size (length in base pairs) for visualization and purification purpose by an electrical 
field, because DNA is negatively charged as it has phosphate group. 
Amplification products through agarose gel matrix migrate toward a positive electrode 
but the rate of migration depends on gel density and length of DNA fragments. To 
accurately determine the size of DNA fragment in the gel matrix, DNA ladder (array of 
DNA fragments of known size) from (PEQ gold ultra low range DNA ladder I) was 
used that runs alongside DNA samples and has defined band sizes. 
The 2% agarose gel electrophoresis was performed for isolated RNA and 5% 
agarose gel electrophoresis was performed for DNA after PCR. Samples were 
prepared, by mixing with a loading buffer, which contains bromophenol blue (acts as 
staining dye that is able to absorb UV radiation) and GelRed (an intercalating nucleic 
acid fluorescent dye illuminates around 312 nm of UV wave length). Loading buffer 
was prepared in concentration of 1:2000 ratio volumes GelRed to bromphenol blue, 
bands were photographed, using UV transilluminator. The running buffer was TEA 
buffer and gels were run within 100 Voltage for 20-40 min at RT.  
 
2.14 Protein measurement 
BCA protein assay reagent A and B (Pierce, USA) was used for protein 
measurement, as indicated in the manufactures protocol. 
 
2.15 Western blot 
Western blot is a protein immunoblot method, used to separate different proteins 
according to their length of the polypeptide by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) and subsequent detection of target protein by a 
specific antibody on the membrane after blotting. 
 
Sample preparation  
After protein quantification, using BCA protein assay kit, the same amount of proteins 
in µg/µl of samples were mixed with tris glycine X2 SDS, then heated at 95°C for 5 
min for denaturation.  
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Polyacrylamide gel preparation                                                     
 
 
 
 
 
 
 
 
Table 19. 8% Polyacrylamide gel preparation (upper and lower) gels. 
 
Marker: 6µl of Novex ® Sharp protein standard marker from invitrogen LC5800 was 
used to determine protein molecular weight. Gel run was started with 90 Voltage then 
changed to 120 Voltage until the protein bands are at the bottom of the gel. 
 
Blotting OF PVDF membrane 
Semidry method was used for blotting proteins on a hydrophobic polyvinylidene 
difluoride (PVDF) membrane. The membrane was activated with 100% methanol and 
equilibrated in semidry buffer for 30 sec and whartman paper were seaked in semidry 
buffer. Blotting was performed with Trans blot turbo transfer system at 25 Voltage for 
10 min. 
Only for EGFR proteins, the tank method was used for blotting on hydrophobic 
polyvinylidene difluoride (PVDF) membranes and it was performed at 100 Voltage  
for 2 hr at RT. 
 
Blocking 
This step was performed to block unspecific binding proteins on a hydrophobic 
polyvinylidene difluoride (PVDF) membrane 
- Blocking buffer for non-phosphorylated proteins: 
 5% (w/v) non fat dry milk in TBST was used for 1 hr at RT with rotation. 
- Blocking buffer for phosphorylated proteins: 
 5% (w/v)  BSA in TBST was used for 1 hr at RT with rotation. 
 
Primary antibody  
Membranes were incubated over night with primary antibodies, diluted in TBST at 
4°C. 
Lower gel 
Solution 
 
Amount / Gel 
Separating buffer 7.3  ml 
Acrylamide          2.65  ml 
TEMED          17.5  µl 
APS             60  µl 
Upper gel 
solution 
 
Amount / Gel 
Stacking buffer  3.8  ml 
Acrylamide          0.85  ml 
TEMED          3.75  µl 
APS          37.5  µl 
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Secondary antibody: 
The IgG Horseradish peroxidase (HRP) anti mouse or rabbit was used, according to 
each species for 1 hr at RT with rotation. 
 
Developing 
According to LumiGlo kit protocol, development was done by an auto processor X-
ray film detector (Optimax mammo-X-ray film processor) in a darkroom. X-ray film 
(Amersham hyper chemiluminescence films) was used for detection of 
chemiluminescent signals from the membrane, after putting it in a light proof cassette 
and exposing it for an appropriate time period, then the film was developed.  
Scanned x-ray film was analyzed by Adobe photoshop and Microsoft excel for 
densitometric comparison of detected bands relative to housekeeping protein β actin.  
 
2.16 Zymography 
For zymography, the proteins of the supernatant, which was treated with UVA, Trolox 
and lactic acid, were concentrated by using protein concentrators 9K MWCO, 7m 
(thermo scientific, Germany). Concentrated supernatants were diluted 1:1 in 2X tris-
glycine SDS buffer without heating and subsequently electrophoresis was performed 
with a 10% tris-glycine gel, containing 0.1% gelatine (invitrogen, Germany). Gel run 
was performed at 125 Voltage for 90 min, followed by incubation in renaturating 
buffer (invitrogen, Germany) at RT. After incubating overnight in the developing 
buffer (invitrogen, Germany) they were stained with Simply blue safestain for 1 hr 
(invitrogen, Germany). The activity and concentration of MMP2 and MMP9 proteases 
has analyzed by measuring the size of digested bands in the gelatin gels normalized 
to the number of cells. The size of digested bands was quantified by measuring the 
cumulative intensity of pixels within the digested band with ImageJ (section from 
Baban et al., in press). 
 
2.17 uPA assay  
Quantitative detection of human uPA was performed according to uPA (URK) human 
ELISA kit (abcam, Germany) protocol. Briefly, supernatant of IM and MM cells treated 
with UVA, Trolox or lactic acid were concentrated by using protein concentrators, 9K 
MWCO, 7m (as described before in paragraph 2.16). The concentrated supernatant 
was applied to the precoated wells with uPA antibody. After washing, HRP was 
 
 
 ! !!!!!56! !! !
56 C. Material and methods 
added to wells to link it with uPA antibody. After washing, the human uPA 
concentration in the supernatant was measured in a microplate reader at 450 nm 
optical density (section from Baban et al., in press). 
 
2.18 In vitro cell invasion assay  
Cell invasion assay was performed, according millipore cell invasion assay protocol 
(millipore, Germany). Briefly, 250000 melanoma cells were incubated per insert, for 
24 hr with and without treatment and the fraction of invaded cells was determined 
fluorometrically, using fluorescence plate reader with a 480/520 nm filter set (section 
from Baban et al., in press). 
 
2.19 Skin reconstructs model 
Skin reconstruct model is a three dimensional (3D) skin culture that consists of 
dermal layers, which is a mixture of normal human fibroblast within a biocollagen 
matrix and epidermis layer. Epidermis layer contains normal human keratinocytes 
and melanoma or melanocytes that were seeded on dermas layer. Using the skin 
reconstruct mode, we are able to fill the gap between in vitro experiments in human 
cells and in vivo experiments in mice. Skin reconstructs were prepared in 
collaboration with (Dr. Tobias Sinnberg, working group of Prof. Birigit Schittek, 
University of Tuebingen). To investigate the influence of UVA irradiation on skin 
reconstructs, glucose uptake, lactate production and transketolase activity were 
measured in different conditions in skin reconstructs lysate and the supernatant of 
skin reconstructs as described before.  
For immunohistochemistry, after fixation with histofixation solution (4% formalin) 
overnight, skin reconstructs were paraffin embedded, serially sectioned using 
microtome. 2µm thick sections were seated on Superfrost (poly-L-lysin) glass slides, 
and then analyzed by H&E staining and S100 antibody, which is a specific antibody 
for human melanoma cells (staining with H&E and treating with S100 antibody were 
done by Histopathology Department of Dermatology hospital, Tuebingen). 
 
2.20 Statistical analysis  
Data are shown as the mean with standard deviation of at least three independent 
experiments and statistical significance was tested with Student’s t-test and a two 
sided p value < 0.05 was considered significant. 
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C. Results 
1. Role of ultraviolet (UV) radiation in progression and invasion of melanoma 
cells 
1.1 UVA radiation decreased survival and viability of melanoma cells 
We investigated the effect of different UVA radiation doses on survival and viability of 
human melanoma cells (initial melanoma derived from vertical horizontal growth 
phase (IM) and metastasizing melanoma (MM)) by determination of viable cell 
number with trypanblue and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT), before and after the experiment (figure10) (section from Baban et al., 
in press). 
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Figure 10. Influences of UVA irradiation on cell survival and viability. 
Melanoma cell lines from initial melanoma (IM) and metastasizing melanoma (MM) were irradiated 
with different doses from 4 to 10 J/cm2 of UVA three times daily for 4 consecutive days.  
 a-b. Trypanblue was used for viable cell number determination. 
The number of cells after experiment relative to number of cells at beginning of the experiment is 
displayed. The number of cells decreased in a dose dependent manner upon UVA irradiation. Data 
are shown as mean value of at least three independent experiments with standard deviation (section 
from Baban et al., in press). 
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c-d. MTT was used to determine the number of viable cells. Displayed is the MTT viability relative to 
unirradiated control. The MTT viability decreased in a dose dependent manner upon UVA irradiation. 
Data are presented as mean values of at least three independent experiments with standard deviation 
(section from Baban et al., in press). 
 
The decrease in cell viability was moderate at doses of 4 J/cm² and 6 J/cm², but a 
significant decrease in MTT viability assay (students t-test; p<0.01) was observed 
from 6 J/cm2 to 8 J/cm2 in IM cells (figure 10 c). 
 
1.2 UVA induced glucose consumption and lactate production 
Most proliferating tumor cells are characterized by enhanced glucose consumption 
and increased lactate production. To investigate the influence of UVA radiation on 
glucose uptake and lactate production, melanoma cells were irradiated three times 
daily for 4 consecutive days (figure 11) (section from Baban et al., in press). 
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Figure 11. UVA induced a dose dependent upregulation of the Warburg effect.  
Melanoma cell lines from initial melanoma (IM) and metastasizing melanoma (MM) were irradiated 
with different doses from 4 to 10 J/cm2 of UVA three times daily for 4 consecutive days and glucose 
consumption and lactate production relative to cell number was measured.  
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a. Repetitive UVA irradiation with different UVA doses increases glucose consumption relative to 
control in a dose dependent manner. Data are presented as mean values of at least three 
independent experiments with standard deviation (section from Baban et al., in press). 
b. Repetitive UVA irradiation with different UVA doses increased lactate production and glucose 
consumption relative to control in a dose dependent manner. Data are presented as mean values of at 
least three independent experiments with standard deviation (section from Baban et al., in press). 
   
Glucose consumption and lactate production are increased upon UVA radiation. This 
effect was observed for different doses of UVA irradiation, partially showing a dose 
dependent upregulation of the Warburg effect (figure 11).  
 
Since irradiation with 6 J/cm2 represents a physiological relevant dose during normal 
sun exposure (Baczynska et al., 2013; Gerber et al., 2002; Mecherikunnel and 
Duncan, 1982; Miyamura et al., 2011; Parisi and Wong, 2000; Turnbull and Parisi, 
2003) and higher doses in our experiments had a strong effect on MTT viability and 
cell survival, further experiments were performed with an irradiation dose of 6 J/cm2 
(figure 12) (section from Baban et al., in press). Figure 2
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                                                                                                 (section from Baban et al., in press) 
Figure 12. UVA significantly induced Warburg effect.  
Melanoma cell lines from initial melanoma (IM) and metastasizing melanoma (MM) were treated 
repetitively with 6 J/cm2 UVA three times daily for 4 consecutive days. 
  !
!!!!!60! !! !
60 C. Results 
a-b. Repetitive UVA irradiation with 6 J/cm2 increased glucose consumption (students t-test; p<0.01) 
and lactate production (students t-test; p<0.05) in IM cells. Glucose consumption and lactate 
production are displayed relative to cell number. Data are presented as mean value with standard 
deviation of at least four independent experiments (section from Baban et al., in press). 
c-d. UVA irradiation with 6 J/cm2 increased glucose consumption (students t-test; p<0.01) and lactate 
production (students t-test; p<0.05) in MM cells. Glucose consumption and lactate production are 
displayed relative to cell number. Data are presented as mean value with standard deviation of at least 
five independent experiments (section from Baban et al., in press). 
e-f. UVA irradiation with 6 J/cm2 increased glucose consumption and lactate production compared to 
unirradiated control, with different genetic background in IM and MM cells. Data are presented as 
mean value with standard deviation of at least three independent experiments (section from Baban et 
al., in press). 
 
Upon UVA irradiation with 6 J/cm2, melanoma cell lines showed significant (students 
t-test; p<0.01) upregulation of UVA induced Warburg effect by increased glucose 
consumption (figure 12 a and c) and lactate production (figure 12 b and d).  
Despite different genetic background every IM and MM investigated, tended to 
induce glucose consumption (figure 12 e) and lactate production (figure 12 f) with 6 
J/cm2 UVA. 
Therefore,  further experiments were performed with an irradiation dose of 6 J/cm2. 
 
1.3 UVA decreased pH value of the medium 
Different melanoma cell lines showed increased glucose consumption and lactate 
production upon UVA radiation. To investigate it melanoma cells also secrete not 
only lactate but also lactic acid, the pH in the medium was measured after UVA 
radiation (figure 13) (section from Baban et al., in press). 
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                                                                                          (section from Baban et al., in press) 
Figure 13. UVA decreased pH value of the medium. 
  !
!!!!!61! !! !
61 C. Results 
Melanoma cell lines from initial melanoma (IM) and metastasizing melanoma (MM) were treated 
repetitively with 6 J/cm2 UVA three times daily for 4 consecutive days, then pH measurement was 
performed.   
a-b. The pH values are displayed after UVA radiation, repetitive UVA irradiation with 6 J/cm2 
significantly (students t-test; p<0.01) decreased the pH value of the IM and MM cell lines. Data are 
presented as pH value of the medium as mean value of at least three independent experiments with 
standard deviation (section from Baban et al., in press). 
 
As a consequence of increased release of lactic acid in to the medium, the pH in the 
medium decreased significantly (students t-test; p<0.01) compared to unirradiated 
control (Figure 13). Increased acidity or decreased pH value of media after UVA 
treatment indicates that UVA induces the Warburg effect. 
 
1.4 Effect of antioxidant on Warburg effect 
Since exposure to UVA irradiation generates reactive oxygen species (ROS) 
(Meewes et al., 2001) we tested whether UVA-induced Warburg effect in melanoma 
cells is ROS mediated by coincubation with ROS quencher Trolox. Cells were treated 
with Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) (Sigma Aldrich, 
Germany) during the irradiation regimen with a dose of 20µM, which is similar to 
doses observed in plasma (20-100µl/l) after oral Trolox treatment (figure 14) (section 
from Baban et al., in press). 
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                                                                                                        (section from Baban et al., in press) 
Figure 14. UVA increased Warburg effect is partially mediated via reactive oxygen species 
(ROS). 
  !
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62 C. Results 
Melanoma cell lines from initial melanoma (IM) were treated repetitively with 6 J/cm2 UVA three times 
daily for 4 consecutive days then glucose consumption and lactate production with addition of ROS 
quencher relative to cell number were measured.  
a-b. Treatment of melanoma cells with and without ROS quencher Trolox and repetitive UVA 
irradiation with 6/cm2. ROS quencher Trolox significantly (students t-test; p<0.05) attenuates UVA 
induced glucose consumption and lactate production. Data are presented as mean value with of at 
least three independent experiments with standard deviation (section from Baban et al., in press). 
 
The UVA induced increase in glucose consumption and lactate production compared 
to unirradiated control was mediated by ROS, since treating cells with ROS quencher 
Trolox partially attenuated the Warburg effect (figure 14). 
 
1.5 Effect of glycolysis inhibitor 
Additionally the effect of UVA induced increase in glucose consumption and lactate 
production in the presence of the inhibitor of glycolysis was investigated, to verify it 
UVA enhanced glucose consumption and lactate production is related to enhanced 
glycolysis. Melanoma cell lines from IM were treated with or without the inhibitor of 
glycolysis, 2-deoxy-D-glucose (2-DG), which reversely blocks activity of glucose 
kinase, a key enzyme of the glycolytic pathway, within a concentration 5.5mM of 
glycolytic inhibitor 2-DG during UVA irradiation (figure 15) (section from Baban et al., 
in press). 
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 (section from Baban et al., in press) 
Figure 15. UVA induced Warburg effect is inhibited by glycolytic inhibitor. 
  !
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63 C. Results 
Initial melanoma (IM) cell lines were treated repetitively with 6 J/cm2 UVA three times daily for 4 
consecutive days then glucose consumption and lactate production relative to cell number with or 
without addition of glycolytic inhibitor was measured.  
a-b. UVA induced glucose consumption and lactate production could be decreased significantly 
(students t-test; p<0.05) in the presence of 2-deoxy-D-glucose (2-DG). Glucose consumption and 
lactate production are presented as mean value with standard deviation of triplicates as representative 
of at least four independent experiments (section from Baban et al., in press). 
 
In consequence, we found that 5.5 mM of 2-deoxy-D-glucose (2-DG) significantly 
(students t-test; p<0.05) diminished UVA induced glucose consumption and 
increased lactate production (figure 15).  
 
1.6 UVA radiation enhanced transketolase activity  
Transketolase is a key enzyme of the pentose phosphate pathway, which is highly 
expressed in many tumors and is used as an important prognostic tumor marker 
(Langbein S et al., 2006). To determine the effect of UVA radiation on the activity of 
transketolase enzyme, melanoma cell lines from IM and MM were irradiated with 
different doses from 4 to 10 J/cm2 of UVA three times daily for 4 consecutive days. 
Afterwards, transketolase activity relative to cell number was measured with a 
colorimetric assay (figure 16) (section from Baban et al., in press). 
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                                                                                     (section from Baban et al., in press) 
Figure 16. UVA radiation enhanced transketolase activity.  
Repetitive UVA irradiation with different doses three times daily for 4 consecutive days in melanoma 
cell lines from initial melanoma (IM) and metastasizing melanoma (MM).  
a. UVA irradiation with 4 to 10 J/cm2  increased transketolase ctivity relative to control partially in a 
dose dependent manner. Data are shown as mean value of at least three independent experiments 
with standard deviation (section from Baban et al., in press). 
b. UVA irradiation with 6 J/cm2 increased tranketolase activity compared to unirradiated control, with 
different genetic background in IM and MM cells. Data are presented as mean value with standard 
deviation of three independent experiments (section from Baban et al., in press). 
 
Different doses of UVA irradiation, partially showing a dose dependent upregulation 
of transketolase activity (figure 16 a) and despite different genetic background every 
IM and MM cell line, investigated was tended to induce transketolase activity (figure 
16 b) upon UVA treatment with 6 J/cm2 UVA. 
 
1.7 Effect of antioxidant on transketolase activity 
To investigate the effect of UVA irradiation on transketolase activity and whether UVA 
irradiation induces transketolase activity via ROS, different melanoma cell lines from 
IM and MM were irradiated with 6 J/cm2 and treated with and without ROS quencher 
Trolox at a dose of 20µM during the irradiation course, transketolase activity was 
measured using a colorimetric assay (figure 17). 
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                                                                                   (section from Baban et al., in press) 
Figure 17. UVA radiation enhanced transketolase activity was partially mediated via ROS.  
Repetitive UVA irradiation with 6 J/cm2 of UVA enhanced transketolase activity in initial melanoma 
(IM) and metastasizing melanoma (MM) cells and additional treatment with the ROS quencher Trolox 
attenuated this effect. Displayed is the transketolase activity relative to cell number, and as 
representatives of three independent experiments with standard deviation (section from Baban et al., 
in press). 
 
Simultaneously, increased transketolase activity upon treatment with 6 J/cm2 of UVA 
was visible in investigated melanoma cells. This UVA enhanced transketolase activity 
in IM cells was strongly d pe dent on UVA induced ROS, as addition of the ROS 
quencher Trolox attenuated UVA induced transketolase activity (figure 17).  
   
1.8 Persistence of UVA induced Warburg effect after UVA radiation 
To test whether the UVA induced Warburg effect persists beyond cessation of UVA 
treatment, melanoma cells from IM were UVA irradiated with 6 J/cm2 for 4 days and 
afterwards seeded for growth on a new plate for another 5 days without irradiation 
(figure 18 a). Subsequently, glucose consumption, lactate production and 
transketolase activity with and without ROS quencher Trolox were measured (figure 
18 b-d) (section from Baban et al., in press). 
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Figure 18. UVA enhanced Warburg effect and transketolase activity is partially ROS mediated 
and persists 5 days after UVA treatment.  
a. Melanoma cell lines were irradiated 4 days with subsequent recovery for 5 days. 
b-d. Glucose consumption, lactate production and transketolase activity relative to cell number were 
measured before and after the experiment, UVA enhanced glucose consumption, lactate production 
and trasketolase activity was still significantly (students t-test; p<0.01) increased 5 days after the last 
UVA irradiation (figure 9 b-d). This long term effect of UVA induced glucose consumption and lactate 
production was comparable in magnitude to the immediate UVA induced Warburg effect and was also 
ROS mediated as addition of ROS quencher Trolox decreased this long term persistence (section 
from Baban et al., in press). 
 
When compared to unirradiated controls, UVA mediated induction of glucose 
consumption and lactate production continued 5 days after cessation of the last UVA 
irradiation (figure 18 b-c). Again, this UVA induced long term persistence of elevated 
glucose consumption and lactate production was partially ROS mediated, similar to 
the immediate UVA induced Warburg effect, as addition of ROS quencher Trolox 
again reduced this long term persistence (figure 18 b-c). Similar to the UVA induced 
Warburg effect, UVA induced transketolase activity also persisted (figure 18 d) even 
5 days after irradiation and was still significantly higher than in unirradiated controls. 
This UVA induced persistent increase in transketolase activity could be partially 
attenuated by the ROS quencher Trolox (figure 18 d) (section from Baban et al., in 
press). 
 
1.9 Measurement of influenced UVA irradiation on different metabolomics by       
NMR spectroscopy 
To further analyze UVA induced metabolic changes, we investigated the production 
and consumption of different metabolites in the supernatants and melanoma cell 
pellets with NMR analysis in collaboration with the University of Regensburg (Prof 
Gronwald). 
1.9.1 Detection of UVA induced Warburg effect by NMR spectroscopy 
We investigated in greater detail UVA induced Warburg effect by NMR spectroscopy 
in the supernatants of control and UVA irradiated melanoma cells. Melanoma cell 
lines from IM and MM were irradiated with 6 J/cm2 of UVA three times daily for 4 
consecutive days, without recovery (figure 19). According to the NMR protocol, 
sample preparation was performed, which described in the material and method 
section.  
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Figure 19. UVA induced Warburg effect analyzed by NMR spectroscopy. 
UVA induced Warburg effect in the supernatant of initial melanoma (IM) and metastasizing melanoma 
(MM) cells was investigated by NMR spectroscopy. Glucose consumption and lactate production 
significantly (students t-test; p<0.05) increased by UVA irradiation and were normalized to mg of total 
cell protein content. Data are presented as mean value with standard deviation of three independent 
experiments. 
 
The NMR spectroscopy result of UVA induced Warburg effect showed increased 
glucose consumption and lactate production, which is confirming our result of UVA 
induced Warburg effect by color enzymatic method (figure 12). The results are 
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displayed in µmol/mg as they were normalized to mg of total cell protein content in 
melanoma cell lines (figure 19).  
 
1.9.2 Investigation of UVA induced differences in metabolomics of melanoma 
cells in the supernatant by NMR spectroscopy 
To investigate further UVA induced metabolic changes, we analyzed the secretion 
(figure 20 a) or uptake (figure 20 b) of different metabolites in the supernatant of 
control and UVA irradiated melanoma cell lines from IM and MM by NMR 
spectroscopy (figure 20 a and b). Comparision of the metabolism of different cancer 
cells and primary cells revealed differences in some metabolites already discussed in 
literature, as some of these metabolites have been investigated in these studies 
(Scott DA.et al., 2011; Dettmer et al., 2013).  
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Figure 20. Change of metabolites upon UVA irradiation in the supernatant of melanoma cells.  
Change of metabolites in the supernatant of melanoma cell lines from initial melanoma (IM) and 
metastasizing melanoma (MM) with and without 6 J/cm2 UVA irradiation.  Displayed are levels relative 
to mg of total cell protein content and data are presented as mean value with standard deviation of 
three independent experiments. 
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a. Secretion of metabolites changed upon UVA irradiation. Treatment with UVA irradiation significantly 
(students t-test; p<0.05) increased secretion of formic acid and pyruvic acid in the supernatant of IM 
and MM cells.  
b. Treatment of melanoma cells with UVA irradiation changed consumption of metabolites in the 
supernatant and the consumption of L-isoleucine, threonine, valine, tyrosine, glutamine, arginine, 
phenylalanine, leucine and L-pyroglutamicacid was significantly (students t-test; p<0.05) increased 
upon UVA irradiation in IM cells.  
 
The secretion of different metabolites in the supernatant of melanoma cells from IM 
and MM significantly (students t-test; p<0.05) increased secretion of formic acid and 
pyruvic acid upon UVA irradiation (figure 20 a).  
Furthermore, the consumption of metabolites in the supernatant of melanoma cell 
lines from IM was significantly (students t-test; p<0.05) increased for L-isoleucine, 
threonine, valine, tyrosine, glutamine, arginine, phenylalanine, leucine and L-
pyroglutamicacid consumption and for MM only tyrosine, phenylalanine and L-
pyroglutamicacid consumption was significantly (students t-test; p<0.05) increased, 
upon UVA irradiation (figure 20 b). 
  
1.9.3 Investigation of UVA induced differences in metabolomics of melanoma 
cells in the pellets by NMR spectroscopy  
Furthermore, UVA induced metabolic changes were investigated in the melanoma 
cell pellets. The concentration of metabolites inside melanoma cells from IM and MM 
of control and UVA irradiated cells was detected by NMR spectroscopy  (figure 21).  
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Figure 21. Change of metabolites upon UVA irradiation in the melanoma cell pellets.  
Change of metabolites in the melanoma cell pellets of melanoma cells from initial melanoma (IM) and 
metastasizing melanoma (MM) with and without 6 J/cm2 UVA irradiation are displayed relative to mg of 
total cell protein content in µmol/mg and data are presented as mean value with standard deviation of 
three independent experiments. 
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The experiments showed, that UVA irradiation changed the metabolism of all 
metabolites investigated (alanine, L-isoeudine, threonine, lactica acid, valine, 
acetone, formic acid, methanol, tyrosine, acetic acid, glutamic acid, glycine, succinic 
acid, fumaricacid, 2-oxoglutaric acid, D-glucose-α, D-glucose-β, myo-inositol, 
arginine, 2-oxoiso caproicacid, asparagines, choline, cis-4-hydroxy-D-proline, 
phenylalanine, leucine, taurine and adenine compound) in the melanoma cell pellets 
from IM and MM. But these differences were heterogeneous among the different 
melanoma cell lines (WM 115, WM 793 and WM 266-4).    
Treatment with UVA irradiation changed the production of the metabolite choline 
significantly (students t-test; p<0.05) in initial melanoma (WM 793) cells and 
production of the metabolites alanine, lactic acid, formic acid, cis-4-hydroxy-D-
proline, leucine and adenine compound was changed significantly (students t-test; 
p<0.05) in metastasizing melanoma (WM 266-4) cells (figure 21).  
 
1.10 Investigation of UVA induced cell signaling pathways  
UVA irradiation induced metabolic changes (figure 19, 20 and 21) and UVA induced 
Warburg effect persists beyond the last UVA irradiation (figure 18) and metabolic 
changes, induced by UVA irradiation could have functional relevance for tumor 
progression. In order to investigate the complex signal transduction mechanisms, 
which are responsible for UVA induced metabolic changes we analyzed early UVA 
induced signaling events, which are known in other dermal cells. Epidermal growth 
factor receptor (EGFR) and insulin-like growth factor receptor (IGFR) are early 
targets of UVA signaling. 
Akt is a protein kinase that involved in PI3K/AKT/mTOR signaling (Bunney and 
Katan, 2010; Majewski et al., 2004). Interestingly, Akt phosphorylation at serine 473 
is present in the majority of immunohistologically investigated melanomas (Dhawan 
et al., 2002) and it has been shown that increased glycolysis and overexpression of 
TKTL1 is correlated with the activation of Akt (Elstrom et al., 2004; Langbein et al., 
2006) and activation of Akt is dramatically increased with melanoma progression (Dai  
DL et al., 2005). 
Furthermore, we analyzed hypoxia inducible factor 1 alpha (HIF1α), which mediates  
transcription of different target genes, associated with glycolysis and involved in 
various cellular processes in hypoxic microenvironment (Demaria et al., 2010). The 
upregulation of HIF1 in many tumors such as head and neck cancer, cervical cancer 
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and renal cell carcinoma induced by hypoxia are associated with tumor progression 
(Kuphal et al., 2010). It has been shown, that in malignant melanoma even in 
normoxic condition, HIF1 activity is increased, due to constitutive HIF1α activation 
that is regulated by ROS (Kuphal et al., 2010). Poly ADP ribose polymerase 1 
(PARP1) is an enzyme which has a role in DNA damage signaling and DNA strand 
break repairs, expressing its functionality by binding to damaged DNA (Polo and 
Jackson, 2011). 
 
1.10.1 EGFR and IGFR internalization by UVA 
Epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor 
(IGFR) are early targets of UVA signaling and it is known that EGFR and IGFR 
signaling cascades are important during UV radiation mediated stress signaling (El-
Abaseri et al., 2006; Lopez-Camarillo et al., 2012) (Baban et al., in press). After 
activation both receptors are internalized from the surface of the membrane. To 
investigate the role of UVA irradiation on EGFR and IGFR signaling of melanoma 
cells, internalization of the EGFR and IGFR population was measured indirectly by 
detection of EGFR and IGFR on cellular surface with fluorescence labeled antibodies 
by FACS analysis (figure 22).  
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Figure 22. UVA induced internalization of EGFR and IGFR.  
a-b. The fluorescence activity of EGFR and IGFR stained with fluorescent antibodies on the cellular 
surface of melanoma cells from initial melanoma (WM 793) treated with and without 6 J/cm2 UVA 
irradiation was measured with FACS. The mean fluorescence intensity of UVA treated melanoma cells 
decreases significantly (students t-test; p<0.05) compared to control, showing enhanced 
internalization of EGFR and IGFR. Data are presented as mean value of three independent 
experiments with standard deviation. 
 
  !
!!!!!76! !! !
76 C. Results 
We found a significant decrease in the EGFR of and IGFR population on cellular 
surface upon UVA treatment (figure 22). These results point to a higher UVA induced 
turnover of EGFR and IGFR and to a UVA induced activation of EGFR and IGFR.  
  
1.10.2 EGFR activation  
To investigate UVA induced EGFR activation, the level of phosphorylated (Tyr 1068) 
EGFR was determined with Western blot. The expression of phosphorylated EGFR 
(pEGFR) within the melanoma cells from IM was analyzed with and without UVA and 
normalized to the expression of beta actin (ß actin) as a house keeping protein. We 
could see a slight increase of phosphorylated EGFR (pEGFR) upon UVA irradiation. 
UVA irradiation significantly (students t-test; p<0.05) increased the level of 
phosphorylated EGFR (pEGFR) in initial melanoma (793WM) cell line (figure 23).  
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•     UVA irradiation enhances activation of EGFR 
•     UVA irradiation enhances activation of  Akt. 
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1.13   EGFR and Akt activation 
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1.13   EGFR and Akt activation 
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Figure 23. UVA irradiation enhanced activation of EGFR. 
Melanoma cells from initial melanoma (IM) were irradiated with and withou  6 J/cm2 UVA three times 
daily for 4 consecutive days with subsequent detection of phosphorylated (Tyr 1068) EGFR and ß 
actin by Western blot and the level of pEGFR relative to ß actin was quantified densitometrically. Data 
represent the mean of three independent experiments with standard deviatio . 
 
  !
!!!!!77! !! !
77 C. Results 
1.10.3 Akt activation                                                                
Hyperactivation of the protein kinase Akt by phosphorylation at the serine residue 
473 is associated with (Volker et al., 2008) and UVA stimulation of the EGFR may 
activate protein kinase Akt as proliferative factor. In order to analyze the level of 
activated Akt upon UVA irradiation, melanoma cell lines from IM and MM were 
exposed to 6 J/cm2 UVA three times daily for 4 consecutive days and after treatment 
the levels of phosphorylated (Ser 473) Akt was determined by Western blot. 
Repetitive UVA irradiation significantly (students t-test; p<0.05) enhanced the level of 
phosphorylated Akt (pAkt) in IM cells and it was also increased in MM cells (figure 
24) (section from Baban et al., in press). 
 
 
                                                               115WM                               266-4WM                 
                                  
1.13   EGFR and Akt activation 
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•     UVA irradiation enhances activation of EGFR 
•     UVA irradiation enhances activation of  Akt. 
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1.13   EGFR and Akt activation 
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•     UVA irradiation enhances activation of EGFR 
•     UVA irradiation enhances activation of  Akt. 
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1.13   EGFR and Akt activation 
Figure 3
A
c trol UVA
IM
MMB
IM MM
pAkt
(Ser 473)
β actin
E
0
1
2
3
4
5
6
T
ra
n
s
k
e
to
la
s
e
 a
c
ti
v
it
y
UVA
Trolox
+- +-
- - ++
C IM
42 kDa
60 kDa
c ntrol UVA c ntrol UVA
0
1
2
3
4
5
6
T
ra
n
s
k
e
to
la
s
e
 a
c
ti
v
it
y
UVA
Trolox
+- +-
- - ++
MMD
control UVA
IM
L
e
v
e
l 
o
f 
p
A
k
t 
re
la
ti
v
e
 t
o
 β
a
c
ti
n
0,2
0,4
0,6
0,8
1
0,2
0,4
0,6
0,8
1
control UVALe
v
e
l 
o
f 
p
A
k
t 
re
la
ti
v
e
 t
o
 β
a
c
ti
n M
*
T
ra
n
s
k
e
to
la
s
e
 a
c
ti
v
it
y
T
ra
n
s
k
e
to
la
s
e
 a
c
ti
v
it
y
L
e
v
e
l 
o
f 
p
A
k
t 
re
la
ti
v
e
 t
o
 β
a
c
ti
n
L
e
v
e
l 
o
f 
p
A
k
t 
re
la
ti
v
e
 t
o
 β
a
c
ti
n
 
•     UVA irradiation e hances activati n of EGFR 
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                                                                                            (section from Baban et al., in press) 
Figure 24. UVA irradiation enhanced activation of Akt. 
Melanoma cell lines from initial melanoma (IM) and metastasizing melanoma (MM) were treated with 
and without 6 J/cm2 UVA three times daily for 4 days with subsequent detection of phosphorylated 
(Ser 473) Akt and ß actin by Western blot and the level of pAkt relative to ß actin was quantified 
densitometrically. Data represent the mean of three independent experiments with standard deviation  
(section from Baban et al., in press).  
 
 
  !
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78 C. Results 
1.10.4 Transcription of HIF1α and PARP1 by real time PCR 
Hypoxia inducible factors 1 (HIF1) is a transcription factor, which is associated with 
tumor growth and it could be affected by UVA induced ROS. Poly ADP ribose 
polymerase 1 (PARP1) or poly ADP ribose synthase 1 (PARP1) is involved in 
differentiation, proliferation and tumor transformation (Rojo et al., 2012; Wang et al., 
2015), also PARP1 has role in single stranded DNA (ssDNA) breaks repair, which 
can occur after UVA irradiation and with its enzymatic activity NADH is needed, 
which can influence the metabolism. To determine the influences of UVA irradiation 
on expression of HIF1alpha (HIF1α) and PARP1, real time PCR was performed. UVA 
irradiation treatment for 4 days induced slight up regulation of HIF1α and PARP1 
gene expression compared to untreated cells but the influences were not significant 
(students t-test; p<0.05) (figure 25). 
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Figure 25. UVA irradiation influenced HIF1alpha and PARP1 gene expression.  
The transcription level of HIF1alpha (HIF1α) and PARP1 relative to house keeping gene ß actin was 
compared with and without UVA irradiation. The transcription level of HIF1α and PARP1 was slightly 
increased after exposure to UVA irradiation but the changes were not significant. Data are presented, 
as mean value with standard deviation of three independent experiments and it is shown in 2-ΔΔCt in 
logarithmic scale, which means the difference in the target gene between treated and control samples. 
 
1.10.5 Analysis of HIF1α protein expression by Western blot 
To investigate further UVA induction of HIF1α, melanoma cells from IM were 
exposed to UVA and after treatment the levels of HIF1α protein were determined by 
Western blot. The expression of total HIF1α protein within the cell was normalized to 
the expression of ß actin as a house keeping protein. We could see a slight 
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upregulation of HIF1α upon UVA irradiation compared to untreated melanoma cells 
but the increase was not significant (students t-test; p<0.05) (figure 26).   
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Figure 26. UVA irradiation influenced HIF1α expression.  
Melanoma cell lines from initial melanoma (IM) were treated with and without 6 J/cm2 UVA three times 
daily for 4 days with subsequent detection of HIF1α and ß actin by Western blot. The level of HIF1α 
relative to ß actin was quantified densitometrically. Slight upregulation of HIF1α was observed but it 
was unsignificant change upon UVA irradiation. Data represent the mean of three independent 
experiments with standard deviation. 
 
1.11 Effect of UVA radiation on gene transcription of different genes involved in 
DNA repair 
UVA radiation causes DNA damage, could interfere with DNA damage related genes 
that are upregulated upon DNA damage.  
To investigate the expression level of different XP genes that are involved in 
nucleotide excision repair and different pro-apoptotic pathways, real time PCR was 
performed. By real time PCR analysis the effect of UVA irradiation on expression of 
the following genes, like XPA, XPB, XPC, XPD, XPE, XPF, XPG, CHK2, HR23a, 
HR23b, ATM, ATR, BRAC1, BRAC2, BRAC3, ERCC1, BAX, Bcl2, P21, P53 and 
MDM2 was examined (figure 27). 
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Figure 27. Effect of UVA irradiation on gene transcription of different genes involved in DNA 
repair.  
Melanoma cell line (WM 115) was treated with and without 6 J/cm2 UVA three times daily for 4 days, 
the transcriptional levels of XPA, XPB, XPC, XPD, XPE, XPF, XPG, CHK2, HR23a, HR23b, ATM, 
ATR, BRAC1, BRAC2, BRAC3, ERCC1, BAX, Bcl2, P21, P53 and MDM2 relative to house keeping 
gene ß actin were compared with and without UVA irradiation. The transcription level of XPC was 
increased after exposure to UVA irradiation but there were no significant changes in the transcription 
levels of the other genes investigated. Data are presented as mean value with standard deviation of  
three independent experiments and displayed in 2-ΔΔCt logarithmic scale, which means the difference 
in the normalized target gene in the samples with and without UVA irradiation. 
 
The transcription level of XPC is increased more then 10-fold after exposure to UVA 
irradiation but there were no significant changes in the transcription levels of the 
other investigated genes (figure 27).  
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Functional relevance of Warburg effect 
1.12 MMPs and uPA expression in melanoma cells 
An important step in melanoma progression is invasion of adjacent tissue, facilitated 
by proteases like matrix metalloproteinases (MMPs) and urokinase type plasminogen 
activator (uPA) and it was shown that MMP9 and uPA are activated during invasion 
of melanoma cells (Bianchini et al., 2006; Tang et al., 2013). We investigated the role 
of UVA irradiation in melanoma progression and invasion via lactic acid alone, which 
is a major derivate of the UVA induced Warburg effect. Treatment with 20mM lactic 
acid for 12hr is able to induce expression of MMPs and uPA in melanoma cell lines 
from IM and MM (figure 28) (section from Baban et al., in press).               
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Figure 28. MMP and uPA expression are upregulated after exposure to lactate. 
a. Melanoma cells from IM and MM were treated with and without 20mM lactic acid and transcriptional 
levels of MMP1, MMP2, MMP3, MMP9, MMP13, MMP15, TIMP1 and uPA relative to house keeping 
gene ß actin were compared with and without lactic acid. MMP and uPA transcription levels are 
increased after exposure to lactic acid, except MMP1 in initial melanoma cell (WM 793). Data are 
presented as mean value with standard deviation of at least four independent experiments and data 
are displayed in 2-ΔΔCt logarithmic scale, which means the difference in the normalized target gene in 
the treated and untreated samples. (section from Baban et al., in press) 
b. Representative gel pictures of target and control amplicons of the real time PCR.  
 
Lactic acid increased the transcription of MMP2, MMP3, MMP9, MMP13, MMP15 
and uPA except MMP1 in initial melanoma cells (WM 793). In addition we found a 
slight induction of TIMP1 in melanoma cells but compared to the transcription levels 
of most MMPs and uPA these effects of lactate on TIMP1 transcription were 
negligible (Figure 28).  
 
1.13 MMP2 and MMP9 activity 
To show that either UVA irradiation or UVA irradiation associated lactic acid alone is 
capable to induce the secretion of active tumor relevant MMP2 and MMP9, 
melanoma cells from IM and MM were treated with and without UVA irradiation and 
ROS quencher or with lactic acid alone then secretion of active MMP2 and MMP9 
was investigated by zymography (figure 29) (section from Baban et al., in press). 
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Figure 29. Zymography for MMP2 and MMP9 activity. 
a-b. Different melanoma cells from IM and MM were treated with and without 6 J/cm2 UVA or with and 
without 20mM lactic acid and the secretion of active MMP2 and MMP9 was measured with 
zymography. MMP2 and MMP9 expression are displayed relative to untreated expression samples. 
UVA irradiation and lactic acid alone significantly increased (students t-test; p<0.05) MMP2 and MMP9 
secretion and ROS quencher Trolox slightly attenuated the effect. Data are presented as mean value 
of three independent experiments with standard deviation (section from Baban et al., in press). 
c. Melanoma cell line (WM115) was treated with and without UVA or with and without 20mM lactic acid 
then secretion of active MMP2 and MMP9 was measured with zymography. MMP2 and MMP9 
expression is displayed relative to untreated expression samples. UVA irradiation and lactic acid alone 
increased MMP2 and MMP9 secretion. Data are presented as mean value of three independent 
experiments with standard deviation (section from Baban et al., in press). 
 
The result of either UVA irradiation, or UVA irradiation associated lactic acid was 
capable to induce secretion of active tumor relevant MMP2 and MMP9, which was 
performed with zymography indicate that UVA irradiation induced secretion of active 
MMP2 and MMP9 in IM and MM cell line, compared to control and UVA induced 
activity of MMP2 and MMP9 was slightly reduced in the presence of ROS quencher, 
indicating a partially ROS mediated mechanism of UVA induced MMP2 an MMP9 
induction. Furthermore, treatment with lactic acid alone was capable to facilitate 
secretion of MMP2 and MMP9, when compared to control (figure 29) (section from 
Baban et al., in press). 
. 
1.14 uPA activity  
To investigate the effect of either UVA irradiation, or UVA irradiation associated lactic 
acid on the secretion and activation of tumor relevant protease uPA, the activity of 
uPA was measured in melanoma cell lines from IM and MM treated with and without 
6 J/cm2 UVA irradiation, 20µm ROS quencher Trolox and lactic acid alone (figure 30) 
(section from Baban et al., in press). 
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Figure 30. uPA activity induced by UVA irradiation. 
a. Secretion and activation of uPA were measured in melanoma cells (WM 793), which were treated 
with and without 6 J/cm2 UVA, 20µm ROS quencher Trolox, and 20mM lactic acid and normalized to 
number of cells. UVA induced uPA secretion and activation, ROS quencher decreased UVA induced 
uPA secretion and activation (students t-test; p<0.05). Treatment with lactic acid alone significantly 
(students t-test; p<0.05) induced uPA secretion and activation. Data are presented as mean value of 
three independent experiments with standard deviation (section from Baban et al., in press).  
b. Secretion and activation of uPA were measured in melanoma cells (WM 266-4) treated with and 
without UVA and normalized to number of cells. UVA induced uPA secretion and activation. Data are 
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presented as mean value of three independent experiments with standard deviation (section from 
Baban et al., in press). 
 
UVA irradiation induced secretion and activation of uPA in melanoma cells from IM 
and MM cell and UVA induced uPA secretion and activation was slightly reduced in 
the presence of ROS quencher, which indicates a partially ROS mediated 
mechanism of UVA induced uPA induction. Furthermore treatment with lactic acid 
alone was also capable to facilitate secretion and activation of uPA, compared to 
control in (WM 793) melanoma cells (Figure 30). 
 
1.15 UVA enhanced Warburg effect increased invasion via lactate production 
To test whether production of lactic acid, which can be induced by UVA mediated 
ROS, is functionally capable to enhance invasion of melanoma cells from IM and 
MM, we performed in vitro invasion assays. In these assays UVA irradiated 
melanoma cells and control (non irradiated) cells were grown on an artificial collagen 
matrix, where they invade this matrix according to their invasive potential. Melanoma 
cells were treated with and without 6 J/cm2 UVA irradiation, 20µM ROS quencher 
Trolox, 5.5mM glycolytic inhibitor 2-DG and 20mM lactic acid (Figure 31) (section 
from Baban et al., in press). 
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(section from Baban et al., in press) 
Figure 31. Lactic acid and UVA enhanced Warburg effect increased in vitro invasion in a ROS 
dependent way.  
Invasive potential of melanoma ells from IM and MM after treatment with and without 6 J/cm2 UVA, 
20mM lactic acid, 20µm ROS quencher Trolox and inhibitor of glycolysis 2-DG were measured with in 
vitro invasion assay after recovery. UVA radiation as well as addition of lactic acid increased invasive 
potential of melanoma cells while addition of ROS quencher Trolox and inhibitor of glycolysis 2-DG 
decreased invasive potential. Data are presented as mean value with standard deviation of three 
independent experiments. UVA radiation as well as lactic acid alone enhanced in vitro invasion via 
ROS dependent way (figure 31) (section from Baban et al., in press). 
 
In the invasion assay, UVA irradiation significantly (students t-test; p<0.01) increased 
invasion of melanoma cells from IM and MM and this effect was partially ROS 
mediated as the ROS quencher Trolox significantly (students t-test; p<0.01) 
attenuated UVA induced invasion. Similarly, the inhibitor of glycolysis 2-DG 
significantly (students t-test; p<0.01) attenuated UVA induced invasion in IM and MM 
cells. Treatment of melanoma cells with lactic acid alone significantly (students t-test; 
p<0.01) increased invasion to an extent comparable to UVA irradiation. These data 
show that addition of lactic acid can mimic the UVA induced increase of the invasive 
potential in vitro (figure 31). This lactate production subsequently can lead to 
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increased expression of MMPs and uPA, which is resulting in increased invasiveness 
of UVA treated melanoma cells.  
 
1.16 UVA induced invasion is facilitated by MMP and uPA  
To investigate to which extent the UVA or lactic acid induced invasion is facilitated 
either by MMP proteases or by uPA protease, we tested invasive potential of UVA 
treated cells with and without inhibitors of MMP and uPA (figure 32) (section from 
Baban et al., in press). 
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Figure 32. UVA enhanced invasion attenuated by MMP inhibitor GM6001 or uPA inhibitor 
Amiloride. 
Invasive potential of melanoma cells from initial melanoma (IM) and metastasizing melanoma (MM) 
treated with and without repetitive 6 J/cm2 UVA irradiation and with and without 10nM MMP inhibitor 
(GM6001) or 7µM uPA inhibitor (Amiloride) was measured by an in vitro invasion assay. Inhibitors of 
MMP and uPA decreased UVA induced invasion and the effect of the inhibitor was significantly 
influenced in melanoma cells from IM. Data are presented as mean value of three independent 
experiments with standard deviation (section from Baban et al., in press). 
 
Presence of a MMP inhibitor as well as an uPA inhibitor partially abrogated UVA 
induced invasive potential (figure 32), which indicates MMP as well as uPA are 
functionally needed for UVA induced invasion in vitro.  
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2.  Effect of UVA irradiation on melanoma cells in skin reconstructs 
To recapitulate the situation in human skin in vivo more closely, effect of UVA 
irradiation on melanoma cells from IM and MM in the skin reconstruct model was 
investigated. Skin reconstructs are three dimensional (3D) models of human skin, 
composed of a dermal layer, consisting of collagen and fibroblasts and an epidermal 
layer, containing keratinocytes and melanoma cells of different progression level, in 
our experiment were used. Skin reconstructs were prepared in collaboration with Dr. 
Tobias Sinnberg (working group of Prof. Birigit Schittek, University of Tuebingen). 
 
2.1 Warburg effect within the human skin reconstruct tissue 
The skin reconstructs with melanoma cells were irradiated with 6 J/cm2 of UVA three 
times daily for 4 consecutive days and glucose uptake and lactate production was 
measured within the skin reconstruct tissue (figure 33) (section from Baban et al., in 
press). 
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(section from Baban et al., in press). 
Figure 33. Effects of UVA irradiation on Warburg effect in the skin reconstruct tissues. 
The skin reconstructs with melanoma cell lines from initial melanoma (IM) and metastasizing 
melanoma (MM) were treated repetitively with 6 J/cm2 UVA three times daily for 4 consecutive days.  
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UVA irradiation significantly (students t-test; p<0.05) increased glucose uptake and lactate production 
within skin reconstruct tissues with IM and MM melanoma cells. Glucose uptake and lactate 
production value were normalized to total weight of respective skin reconstruct samples. Data are 
presented as mean value with standard deviation of three independent experiments (section from 
Baban et al., in press). 
 
Glucose uptake and lactate production were significantly (students t-test; p<0.05) 
increased upon UVA irradiation within skin reconstruct tissues with melanoma cell 
lines from IM and MM (figure 33).  
 
2.2 Effect of ROS quencher Trolox on UVA induced Warburg effect in the 
human skin reconstructs 
Since exposure to UVA irradiation generates ROS, we tested whether UVA induced 
Warburg effect in skin reconstructs with melanoma cell lines is ROS mediated within 
skin reconstruct tissues (figure 34 a) and supernatant of skin reconstructs (figure 34 
b) by coincubation with 20µm ROS quencher Trolox. 
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Figure 34. UVA induced Warburg effect is partially attenuated by ROS quencher Trolox. 
UVA induced Warburg effect within the skin reconstruct tissues and in the supernatant of different 
melanoma cell lines from initial melanoma (IM) and metastasizing melanoma (MM) with and without 
ROS quencher Trolox was measured. 
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a. UVA induced Warburg effect is partially attenuated by decreasing glucose uptake and lactate 
production within the skin reconstruct tissues when they were treated with 20µm ROS quencher 
Trolox.                    
b. UVA induced Warburg effect is significantly (students t-test; p<0.05) attenuated by decreasing 
glucose consumption and lactate production with UVA treated samples in the supernatant of skin 
reconstructs when they were treated with 20µm ROS quencher Trolox. 
 
In the supernatant of the skin reconstructs glucose consumption and lactate 
production was increased upon UVA irradiation and coincubation with ROS quencher 
Trolox decreased this effect, indicating a partially ROS mediated mechanism of UVA 
induced glucose consumption and lactate production within the skin reconstruct 
tissues and skin reconstruct supernanats (figure 34 a and b).  
       
2.3 Effect of sunscreen product on UVA induced Warburg effect in the human 
skin reconstructs 
Sunscreen product has a protective effect against sunburn, induced by UV radiation 
in human skin (Autier P., 2000; Kaur et al., 2014). To show that sunscreen is capable 
to decrease the UVA induced Warburg effect, we treated human skin reconstruct with 
a sunscreen product during irradiation courses before measuring glucose 
consumption and lactate production in the supernatant of human skin reconstructs 
with and without sunscreen product and additionally with ROS quencher Trolox 
(figure 35).   
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Figure 35. Influence of UVA induced Warburg effect in the supernatant of human skin 
reconstructs with sunscreen product.  
Human skin reconstructs with melanoma cell lines from initial melanoma (IM) and metastasizing 
melanoma (MM) were treated repetitively with 6 J/cm2 UVA three times daily for 4 consecutive days 
with and without sunscreen (Ss) product and 20µm ROS quencher Trolox. The glucose consumption 
and the lactate production were significantly increased upon UVA irradiation and UVA induced 
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increased glucose consumption and lactate production was significantly (students t-test; p<0.05) 
attenuated with 20µm ROS quencher Trolox and this effect with sunscreen (Ss) product was 
attenuated also in the supernatant of skin reconstructs. Data are presented as mean value with 
standard deviation of three independent experiments. 
 
The UVA induced increased Warburg effect in the human skin reconstruct is 
significantly (students t-test; p<0.05) attenuated by application of a sunscreen 
product in MM cells (figure 35).  
 
2.4 Transketolase activity in human skin reconstruct model 
To recapitulate the human skin in vivo more closely, skin reconstructs with different 
melanoma cells from IM and MM were used to detect the influences of UVA 
irradiation on transketolase activity. For measurement of transketolase activity in skin 
reconstructs, the skin reconstruct was weighted and subsequently transketolase 
activity was measured calorimetrically as described above (figure 36). 
 
Figure 3
a
control UVA
b
pAkt
(Ser 473)
β actin
i
0
1
2
3
4
5
6
Tr
an
sk
et
ol
as
e 
ac
tiv
ity
UVA
Trolox
+- +-
- - ++
d
42 kDa
60 kDa
control UVA control UVA
0
1
2
3
4
5
6
Tr
an
sk
et
ol
as
e 
ac
tiv
ity
UVA
Trolox
+- +-
- - ++
e
control UVALe
ve
l o
f p
A
kt
 r
el
at
iv
e 
to
 
β
ac
tin
0,2
0,4
0,6
0,8
1
0,2
0,4
0,6
0,8
1
control UVAL
ev
el
 o
f p
A
kt
 r
el
at
iv
e 
to
 
β
ac
tin
*
42 kDa
60 kDa pAkt
(Ser 473)
β actin
IM (WM 115) MM (WM 266-4)
IM (WM 115) IM (WM 115) MM (WM 266-4) MM (WM 266-4)
IM (WM 793)
MM (WM 266-4)
WM 115 WM 793 WM 1552c WM 35 WM 1205 WM 266-4
U
V
A
 in
du
ce
d 
tr
an
sk
et
ol
as
e 
ac
tiv
ity
 r
el
at
iv
e 
to
 c
on
tr
ol
IM MM
0
1
2
3
4
5
6
7
8
9
10
c
0
0,1
0,2
0,3
0,4
control UVA
skin reconstruct
*
IM (Sbcl2)
Tr
an
sk
et
ol
as
e 
ac
tiv
ity
/m
g
0
0,1
0,2
0,3
0,4
MM (BLM)
Tr
an
sk
et
ol
as
e 
ac
tiv
ity
/m
g
control UVA
skin reconstruct
0
0,1
0,2
0,3
0,4
Tr
an
sk
et
ol
as
e 
ac
tiv
ity
/m
g
control UVA
skin reconstruct
IM (WM 793)
*
f
 
(section from Baban et al., in press) 
Figure 36. UVA irradiation enhanced transketolase activity in human skin reconstructs. 
Human skin reconstructs with melanoma cell lines from initial melanoma (IM) and metastasizing 
melanoma (MM) were treated repetitively with 6 J/cm2 UVA three times daily for 4 consecutive days 
and transketolase activity was determined by a colorimetric assay. Treatment with UVA irradiation 
increased transketolase activity in the skin reconstructs, the effect was significant (students t-test; 
p<0.05) in IM cells only. Data are presented as mean value of three independent experiments with 
standard deviation (section from Baban et al., in press). 
 
Treatment with UVA irradiation increased transketolase activity in skin reconstructs 
with melanoma cells from IM and MM but increase in transketolase activity reached 
significance in skin reconstructs with IM cells (figure 36).  
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2.5 Effect of ROS quencher Trolox on UVA induced transketolase activity in the 
human skin reconstruct model 
To investigate wether UVA induced transketolase activity in skin reconstructs with 
melanoma cell lines from IM and MM is ROS mediated, the skin reconstructs with 
different melanoma cell lines from IM and MM were irradiated with 6 J/cm2 and 
treated with and without ROS quencher Trolox with a dose of 20µM during the 
irradiation course (figure 37). 
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Figure 37. UVA induced transketolase activity attenuated by ROS quencher Trolox. 
Human skin reconstructs with melanoma cell from initial melanoma (IM) were treated repetitively with 
UVA for three times daily for 4 consecutive days with and without Trolox. UVA treatment significantly 
(students t-test; p<0.05) increased transketolase activity in the skin reconstructs but the effect of ROS 
quencher Trolox was not significant (students t-test; p<0.05). Data are presented as mean value of 
three independent experiments with standard deviation. 
 
ROS quencher Trolox attenuated UVA induced transketolase activity in skin 
reconstructs (figure 37).  
 
2.6 Induction of MMP9 and uPA in human skin reconstructs by UVA irradiation 
We want to know, whether UVA irradiation is able directly to induce MMP9 and uPA 
expression. Therefor, effect of UVA irradiation on MMP9 and uPA expression and 
secretion in skin reconstructs with melanoma cells from IM and MM was investigated 
by immunohistochemistry (figure 38) (section from Baban et al., in press). 
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(section from Baban et al., in press) 
Figure 38. Expression of MMP9 and uPA in skin constructs upon UVA irradiation.  
The skin reconstructs with melanoma cells from initial melanoma (IM) and metastasizing melanoma  
(MM) were irradiated with 6 J/cm2 of UVA and the amount of MMP9 and uPA expression in epidermal 
and dermal layer was measured per visual field. 
UVA irradiation was enhanced epidermal and dermal MMP9 expression in skin reconstructs. The 
effect was significantly (students t-test; p<0.05) induced in the epidermal layer of skin reconstructs 
with melanoma cells from IM and MM. UVA irradiation was enhanced epidermal and dermal uPA 
expression in skin reconstructs. Data are presented as mean values of at least three independent 
experiments with standard deviation (section from Baban et al., in press). 
 
UVA irradiation enhanced the expression of MMP9 and uPA tumor relevant 
proteases in skin reconstruct with melanoma cells. UVA irradiation significantly 
increased epidermal MMP9 expression of skin reconstructs with IM and MM cells. 
The result shows induction of tumor relevant MMP9 and uPA proteases upon UVA 
treatment (figure 38). 
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2.7 Invasion 
Irradiation of skin reconstructs with epidermal melanoma cells from IM and MM 
enhanced MMP9 and uPA expression by 6 J/cm2 of UVA (figure 38). We aimed to 
test the functional role of UVA irradiation toward invasion and metastasis of 
melanoma cells. Invasive potential of melanoma cells from IM and MM, using skin 
reconstructs model treated, with and without repetitive UVA irradiation was 
determined by S100 immunostaining (figure 39).  
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(s ction from Baban et al., in press). 
Figure 39. UVA irradiation induced invasion in situ in human skin reconstructs.  
In repetitive UVA irradiated skin reconstructs with epidermal melanoma cells from initial melanoma 
(IM) and metastasizing melanoma (MM) more initial invasion of melanoma cells in the dermis is 
detected with melanoma specific S100 immunostaining compared to control. UVA irradiation 
enhanced invasion in skin reconstructs, the effect was singnificantly (students t-test; p<0.05) induced 
in IM cells. Dermal melanoma cells were counted per field of vision and are displayed as mean value 
with standard deviation of at least three independent experiments. Scale bar represents 70µm (section 
from Baban et al., in press). 
 
We found that pretreatment of UVA with subsequent recovery was capable to 
increase invasion.  
Taken together, we could show that UVA treatment within physiological doses 
directly induced tumor relevant proteases. In addition to this, UVA irradiation 
increased initial dermal invasion of melanoma cells from IM and MM in skin 
reconstructs, which was verified by a histopathologist (Figure 39). 
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3. The role of mitochondrial DNA mutations in progression and invasion of 
melanoma cells 
Functionality of mitochondria can be important for proliferating tumor cells, due to 
their role in metabolic processes and their role in apoptosis. On the other hand 
mutagenic events, due to UVA irradiation, can promote skin cancer onset and 
mutations in mitochondrial DNA (mtDNA), due to UVA irradiation and other sources 
with negative impact on mitochondrial functionality. The mitochondrial 4.9 kb large 
deletion is known to be induced by UVA and ROS and is considered as a marker 
deletion for mtDNA mutations (Berneburg et al., 1999; 2006). The possible role of 
mtDNA common deletion in carcinogenesis is still discussed and the frequency of this 
deletion in melanomas as well as in nevi is still unknown. 
 
3.1 Level of mtDNA common deletion in melanoma 
To investigate the level of mtDNA deletion during carcinogenesis, histological 
samples were collected from four different groups of patients with normal nevi 
(benign), dysplastic nevi, melanoma (<1mm) and melanoma (>4mm).  To avoid 
contamination from adjacent tissue we isolated the target tissue with Laser capture 
microdissection in cooperation with Prof. Röcken, Prof. Bauer (Department of 
Dermatology, University of Tuebingen) and Prof. Seeger (Department of Gynecology, 
University of Tuebingen). Nurgül Düzenli our lab assistant is involved in part of this 
experiment.  
After tissue isolation by Laser capture microdissection and DNA extraction, real time 
PCR was performed to detect the quantity of this deletion in the tissues. To exclude 
bias, due to different age and sun exposure of the patients, the level of common 
deletion of the sample of the target tissue was normalized to a sample of normal skin 
adjacent to the sample from the same patient (figure 40).  
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Figure 40. 
The level of the mitochondrial common deletion decreased during melanoma progression. 
a. In H&E stained histological samples (normal nevi, dysplastic nevi, melanoma <1mm and melanoma 
>4mm samples) the target tissue and control (non tumor epidermis tissues) were excised with Laser 
capture micro dissection.  
b. The transcription level of common deletion was calculated as 2-ΔΔCt values in normal nevi, dysplastic 
nevi, melanoma <1mm and melanoma >4mm samples. The transcription level of common deletion 
above 1 means the transcription level of target tissue was higher than the level in control tissue from 
the same patient. The level of common deletion in melanoma <1mm is higher than the level in control 
tissue and melanoma >4mm is lower than the level in control tissue from the same patient.  
Data are presented as mean value of three independent samples from each group (normal nevi, 
dysplastic nevi and melanoma <1mm) and as mean value of two independent samples for melanoma 
>4mm with standard deviation.  
c. Representative gel pictures of target and control amplicons of the real time PCR. 
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Human mitochondrial DNA deletions are significantly decreased in vivo in melanoma with tumor 
thickness larger than 3mm compared to nevi and melanomas with tumor thickness smaller than 
1mm isolated by laser capture microdissection. 
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Eigentler, Thomas: 
Um die Bedeutung dieser Ergebnissen genauer analysieren zu 
können, untersuchten wir unsere Transplantationsfälle in Relation 
zum Plasmazellgehalt während der Abstoßungsperioden 
hinsichtlich ihres morphologischen Bildes und des klinischen 
Verlaufes, insbesondere auch in Beziehung zu einer potentiellen 
TGP/VAR. 
Eigentler, Thomas: 
klinische Parameter, Morphologieauswertung 
erfolgen anhand akut/und chronischer 
Abstoßung und anhand des 
Plasmazellengehalt, Lokalisation und 
Verteilung der Plasmazellen, TGP, VAR, 
HLA, Panelreaktion, CMV, M/F,F/M 
Bestätigung früherer Ergebnisse hinsichtlich Anzahl der akuten 
Abstoßung, Auftreten einer akuten Abstoßung innerhalb 6 
Monaten, Auftreten einer chronischen Abstoßung innerhalb des 
ersten Jahres. -> Vergleich Rösch : 
 
MATERIAL AND METHODS 
•  Tissue of nevi and dysplastic and  melanoma were isolated with  laser capture microdissection : 
   (25 nevi samples, 26 dysplasticnevi samples, 22melanoma < 1mm samples and 21 melanoma > 3mm samples) 
•  Tumor and epidermal tissue could be extracted with almost no contamination of other tissues. 
•  Non tumor epidermal tissue was isolated with the same meth d. 
•  DNA was  extracted out of samples.  
•  Amount of mt common deletion and mt control gen s (where typically no deletions 
  occur) was measured with real time PCR. 
•  Relative amount of mt common deletion in tumor tissue was compared to amount 
  of mt Common deletion in non tumor tissue (2-∆∆Ct value). 
. Level of mitochondrial common deletion is reduced in most melanoma >3mm. 
•   Level of mitochondrial common deletion is increasd in most melanoma <1mm. 
•   Level of mitochondrial common deletion is  dependent on size of primary tumor. 
•   Possible selection mechanism against mitochondrial common deletion during melanoma 
   progression. 
     
Figure 1:   Laser capture microdissection 
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High frequencies of the mitochondrial 4977bp so called 
common deletion are associated with aging especially 
photoaging, but a possible role of this deletion in tumors 
is still discussed controversial, with reports of varying 
deletion frequencies in different tumors compared to 
control tissue. The frequencies of the common deletion in 
melanomas as wells as nevi are still unknown. Especially 
dysplastic nevi are an important risk factor for the 
development of melanoma. The aim of this study was to 
investigate the frequency of the common deletion in 
melanomas of initial and advanced stages and in normal 
and dysplastic nevi. To accomplish this, samples were 
collected from four different groups of patients with 
normal nevi, dysplastic nevi, initial melanomas with tumor 
thickness smaller than 1mm and advanced melanomas 
with tumor thickness larger than 3mm.  
Each group consists of at least 20 patients and tissue 
adjacent to the lesion of each individual patient of each 
group was used as control.  
Tumor and non-tumor samples were confirmed by an 
independent pathologist, hematoxylin eosin stained and 
then laser capture microdissected with a Laser Capture 
M ic rod issec t ion (LCM2105 ) dev ice to avo id 
contamination with adjacent tissues of each sample. 
Subsequently, DNA extraction and real time PCR for 
detection of the 4977bp common deletion was 
performed. The frequency of common deletion in each 
sample was normalized to the respective control tissue 
of each individual patient. In most of the normal nevi, the 
dysplastic nevi and initial melanomas the frequency of 
the common deletion was higher when compared  the 
adjacent control tissue.  
The average frequency of common deletion in nevi 
samples was approximately 51 times higher than in 
adjacent control tissue.  
This tendency was also visible in the group with 
dysplastic nevi with an average increased frequency of 
approximately 93 times and in the group with initial 
melanomas with an average increased frequency of 
approximately 100 times. Interestingly the frequency of 
common deletion decreased dramatically to an average 
decreased frequency of approximately 0.5 times 
compared to adjacent control tissue. This decrease in 
the frequency of the common deletion was highly 
significant, when compared to the frequencies of nevi 
and initial melanoma. This finding indicates a selection 
mechanism in melanoma against high levels of common 
deletion and its depletion in advanced melanomas could 
serve as a tumor marker. 
 
INTRODUCTION 
Figure 2:   Histological skin sample 
             (Tumor and non tumor tissue)  
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Figure 3: Histological 
specimens for LCM   
Histological samples of nevi, 
dysplastic nevi, melanoma 
with a tumor thickness <1 mm 
and melanoma with a tumor 
th ickness >3 mm were 
analyzed. Target tissue and 
control t issue non-tumor 
epidermal cells were isolated 
w i t h L C M f r o m e a c h 
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0,01 
0,1 
1 
10 
100 
1000 
10000 
melanoma < 1mm  nevi  melanoma  > 3mm Dysplastic nevi 
Figure 4: Box Whisker plot of relative 
level of the common deletion in nevi, 
dysplastic nevi melanoma of <1mm 
and melanoma>3mm applying real time 
PCR in-vivo.  
After LCM total DNA was extracted and in 
subsequent real time PCR the relative 
level of mitochondrial common deletion is 
calculated as 2-ΔΔCt value.  2-ΔΔCt values 
lower than 1 indicate lower amount of 
common deletion in tumor cells compared 
to non-tumor epidermal cells, while values 
above 1 indicate higher amounts. Values 
(2-ΔΔCt) are displayed in logarithmic scale. 
Experiments were done in triplicate and 
data is shown as median with 25% and 
50% Quartile (Box) and with lowest and 
highest values (whisker).  
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Figure 5: Measurement of the common deletion in 25 nevi samples, 26 dysplastic nevi samples, 22 melanoma of <1mm samples and 21 melanoma >3mm  samples by real time PCR in-vivo.  
2-ΔΔCt values lower than 1 indicate lower amount of common deletion in tumor cells compared to non-tumor epidermal cells, while values above 1 indicate higher amounts. Values (2-ΔΔCt) are displayed in logarithmic scale. Experiments were done in triplicate and data is shown in  
2-ΔΔCt ±SEM. In comparison to epidermal cells, melanoma>3mm together show significantly lower levels of the common deletion (student t-test **=p<0.01). 
 
SUMMARY AND DISCUSSION 
•   High amount of mitochondrial common deletion could be a transient phenomenon during  
   early stages of melanogenesis. 
•   In nevi: tendency to higher amounts of common deletion  compare to epidermal tissue. 
•   In dysplastic nevi: tendency to higher amounts of common deletion compared to 
   epidermal tissue. 
RESULT 
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Figure 41. Measurement of the common deletion in 25 nevi samples, 26 dysplastic nevi 
samples, 22 melanoma of <1mm samples and 21 melanoma >4mm samples by real time PCR.  
The PCR result is displayed in 2-ΔΔCt values, lower than 1 indicat  lower amount of common deletion in 
target tissue compared to non tumor epidermal tissue , while values above 1 indicate higher m unts. 
Values 2-ΔΔCt are displayed in logarithmic scale with standard deviation. In comparison to epidermal 
cells, melanoma >4mm together show significantly (student t-test p<0.01) lower levels of common 
deletion. 
 
In histological human skin samples, we found that the average level of human 
common deletion in normal nevi and dysplastic nevi and melanoma >1mm samples 
is significantly higher than in control tissue from the same patient and in melanoma 
>4mm decreases significantly below the level of the control tissue from the same 
patient (figure 41). Interestingly, there is a tendency to high level of common deletion 
in initial melanoma. These findings point to a possible selection mechanism against 
the common deletion during melanoma progression. 
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E. Discussion 
In many patients initial small melanomas are not discovered and patients continue 
solar exposure and it was shown that many patients even increase their sun 
exposure after diagnosis of initial melanoma (Idorn et al., 2013) (Baban et al., in 
press). The effect of a single neonatal high dose of UVB or UVA radiation for 
initiation of melanoma was shown previously in mice (Noonan et al., 2003; Noonan et 
al., 2012). In addition, recent work showed that UVB radiation promotes metastasis 
(Bald et al., 2014). But despite its physiological relevance, it is still not clear how UVA 
irradiation influences progression of human initial melanoma cells (Baban et al., in 
press). 
In this study, we investigated the role of UVA irradiation on metabolism and 
progression of melanoma cell lines from initial melanoma (IM) and metastasizing 
melanoma (MM). We found that UVA irradiation alters metabolism, particularly UVA 
induced production of lactic acid. Furthermore, UVA irradiation as well as high 
concentrations of lactic acid increased expression and activity of MMPs and uPA and 
enhanced invasion in vitro (Baban et al., in press). 
Additionally, we investigated the level of mitochondrial DNA (mtDNA) common 
deletion, which can also be induced by UVA via ROS (Berneburg et al., 1999), in 
normal nevi, dysplastic nevi, melanoma <1mm and melanoma >4mm samples.  
 
1. Influence of UVA on Warburg effect 
1.1 Influence of UVA on Warburg effect in melanoma cells 
For most proliferating tumor cells the preference of aerobic glycolysis with increased 
glucose consumption and lactate production has been described as the Warburg 
effect (Warburg, 1956). The literature indicates that tumor cells benefit from the 
Warburg effect, since part of the glycolysis derived pyruvate can be used as 
precursor substances for further anabolic pathways like amino acid synthesis or fatty 
acid synthesis, as well as cholesterol synthesis (Vander Heiden et al., 2009) (Baban 
et al., in press). Our results demonstrate, that UVA induces the tumor associated 
Warburg effect in melanoma cell lines from initial melanoma (IM) and metastasizing 
melanoma (MM) partially in a dose dependent manner (figure 11). Upon UVA 
irradiation, these cells show an induction of glycolysis (figure 11, 12 and 15) with 
increased glucose consumption and lactate or lactic acid production (figure 11, 12 
and 13). Although it has to be mentioned that UVA irradiation decreased survival of 
  ! !!!105! !! !
105                                                                                                                            E. Discussion 
the tumor cells in a dose dependent way (figure 10), the remaining viable cells have 
a higher rate of glucose consumption and lactate production per cell than 
unirradiated controls (figure 11 and 12) (Baban et al., in press). Melanoma cells from 
IM have elevated rates of UVA induced Warburg effect, compared to melanoma cells 
from MM (figure 11). As a consequence of increased release of lactic acid into the 
medium, the pH in the medium decreased compared to unirradiated control (figure 
13) (Baban et al., in press). Exposure to UVA irradiation generates reactive oxygen 
species (ROS) (Meewes et al., 2001). The metabolic changes we observe, seem to 
be partially mediated by ROS, since addition of ROS quenchers, enabled to prevent 
a UVA induced increase in the Warburg effect (figure 14). Interestingly, the UVA 
induced Warburg effect persisted for 5 days after cessation of the last UVA irradiation 
(figure 18), which could in part be attenuated by ROS quencher Trolox (figure 18) 
(Baban et al., in press). This indicates a long lasting change in the metabolism of 
tumor cells, which goes beyond the time typically needed to repair UVA induced DNA 
damage. The long lasting increased glycolysis could be helpful for melanoma cell 
anabolic pathways, like amino acid synthesis or fatty acid synthesis and cholesterol 
synthesis through pyruvate, which is produced by UVA induced increase in aerobic 
glycolysis.  
 
1.2 Influence of UVA on Warburg effect in skin reconstructs 
Most in vitro experimental skin biology investigations were performed in 
monocultures but accumulating studies suggests, that skin cells behave differently 
when they are cultivated within a three dimensional (3D) culture model, were they 
can interact with other cells (Sun et al., 2006; Mohapatra S et al., 2007; Sun et al., 
2007; Kremer et al., 2001). Therefore, skin reconstructs are more suitable to simulate 
the physiological situation in human skin.  
In the 3D skin reconstruct model, melanoma cells can recapitulate the in situ 
phenotype and the biological characteristic of melanoma progression with the distinct 
growth phases (Meier et al., 2000; Li et al., 2011).  
We used the skin reconstruct model also for our studies. Melanoma cells of different 
progression levels were seeded in the epidermal layer and the skin reconstructs were 
treated with and without UVA irradiation. Subsequently, glucose consumption and 
lactate production within the skin reconstruct tissues (figure 33) or in the supernatant 
of the skin reconstructs (figure 34 b) were measured. Similarly to the results of 
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monoculture experiments, we also found UVA induced increase in glucose 
consumption or uptake and increased lactate production compared to unirradiated 
control (Baban et al., in press). UVA induced Warburg effect in skin reconstructs was 
again partially mediated via ROS, as the ROS quencher Trolox decreased UVA 
induced Warburg effect (figure 34). Before solar exposure, sunscreen products are 
often used, since they are able to absorb and protect skin against skinburn effect 
induced by UV (Autier P., 2000; Kaur et al., 2014). We found that UVA induced 
Warburg effect was attenuated after application of a sunscreen product (figure 35). 
Decrease of UVA induced Warburg effect by a sunscreen product in the skin 
reconstruct model was similar to the effect of Trolox, indicating a protective effect of 
the sunscreen product against UVA induced progression of melanoma.  
In the skin reconstructs high lactate concentrations could also be produced by 
surrounding cells like normal fibroblasts, during UVA irradiation (Morliere et al., 1991; 
Coubomb et al., 1996), as UVA irradiation is able to induce membrane damage 
through lipid peroxidation in fibroblasts and keratinocytes (Moysan et al., 1996: 
Coubomb et al., 1996). This effect is decreased by antioxidant vitamice E in fibroblast 
that where cultivated in 3D matrix models (Coubomb et al., 1996). Indeed, 
keratinocytes and fibroblasts can produce lactate upon UVA irradiation via release of 
lactate dehydrogenase (Morliere et al., 1991). But the additional production of lactate 
by fibroblasts and keratinocytes can enhance the functional consequences of lactate 
production, like MMP9 and uPA expressions in the IM cells and therefore enhance 
progression of IM cells.  
 
2. Influence of UVA on transketolase activity 
2.1 Influence of UVA on transketolase activity in melanoma cells 
Another tumor relevant metabolic change is the activation of the pentose phosphate 
pathway, which provides tumor cells with components such as riboses, needed for 
nucleotide synthesis and nicotinamide adenine dinucleotide phosphate (NADPH), 
which is needed for other anabolic pathways (Boros et al., 1997).  
Transketolase isoform transketolase like 1 (TKTL1) is a main enzyme of the pentose 
phosphate pathway and part of the metabolic network supporting growth of tumor 
cells (Resendis-Antonio et al., 2010) (Baban et al., in press). It has been shown, that 
the expression of TKTL1 gene correlates with total transketolase activity and cell 
proliferation (Hu et al., 2007; Zhang S et al., 2008; Chen H et al., 2009). Furthermore, 
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in many tumors, a strong correlation between the expression of TKTL1 and tumor 
progression was reported (Staiger et al., 2006; Volker et al., 2008). In contrast to the 
work of Mayer A., no expression of TKTL1 in different malignant tumor cells was 
detected (Mayer A et al., 2010). TKTL1 is also used as prognostic marker for highly 
proliferative cancers in cancer therapy (Langbein et al., 2006).  
We showed that UVA irradiation increased transketolase activity (figure 16) and 
despite different genetic background, every IM and MM investigated, tended to 
induce transketolase activity (figure 16 b). This effect was also observed for different 
doses of UVA irradiation, partially showing a dose dependent upregulation of 
transketolase activity (figure 16 a). This UVA enhanced transketolase activity in IM 
cells was dependent on UVA induced ROS, as addition of the ROS quencher Trolox 
reduced UVA induced transketolase activity (figure 17) (Baban et al., in press). 
Interestingly, the UVA induced transketolase activity persisted for 5 days after 
cessation of the last UVA irradiation (figure 18), while its activity could in part be 
attenuated by ROS quencher Trolox (figure 18) (Baban et al., in press), indicating a 
long lasting change in the metabolism of tumor cells, which goes beyond the time 
typically needed to repair UVA induced DNA damage. This long lasting activated 
pentosephosphate pathway could be of advantage for proliferating tumor cells, 
providing tumor cells with riboses, which are needed for nucleotide synthesis and 
nicotinamide adenine dinucleotide phosphate (NADPH), necessary for other anabolic 
pathways (Boros et al., 1997). 
 
2.2 Effect of UVA on transketolase activity in skin reconstructs 
UVA increased transketolase activity in skin reconstructs (figure 36) (Baban et al., in 
press) and this effect was slightly reduced in the presence of ROS quencher Trolox 
(figure 37), indicating a partially ROS mediated UVA induced transketolase activity in 
skin reconstructs. In the skin reconstructs, high transketolase activity could also be 
produced by surrounding cells like keratinocytes and normal dermal fibroblasts 
because during UV irradiation these cells for glucose catabolism turn to oxidative 
phase of pentose phosphate pathway, which is also mediated by ROS (Kuehne et 
al., 2015). Indeed, keratinocytes and fibroblasts can increase transketolase activity 
upon irradiation.  
Taken together, UVA induced, partially mediated by ROS, glycolysis with increased 
glucose consumption and lactic acid or lactate production and transketolase activity 
  ! !!!108! !! !
108                                                                                                                            E. Discussion 
(figure 42). This UVA induced long lasting change in the metabolism of tumor cells 
can support proliferation of the melanoma cells. 
 
Effect of UVA iradiation on melanoma cells: 
•    Increase of Warburg effect : 
        Increase glucose consumption  
        Increase of lactate production  
•     Induction of transketolase activity 
•     Reduction of Warburg effect by antioxidants 
•     Decrease of Warburg effect by inhibito 
      of glycolysis 
•     Changes in amino acid concentrations.  
 
1.16 Summary I 
 Glucose consumption Lactate production 
 Transketose activity 
 Warburg effect 2DG Trolox 
      
UVA 
 
 
Figure 42. Summary of the effect of UVA irradiation in melanoma cells and skin reconstructs 
for Warburg effect and transketolase activity according to our data. 
Increase of Warburg effect via UVA induced increase in glucose consumption and lactate production 
and UVA induced increase of Warburg effect was partially attenuated by ROS quencher Trolox and 
glycolysis inhibitor 2DG, and induction of transketolase activity by UVA irradiation. 
 
 
3. Signal transduction mechanism of UVA induced Warburg effect  
We demonstrated that UVA induced Warburg effect persists even 5 days beyond the 
last UVA irradiation (figure 18), indicating a long lasting change in the metabolism of 
tumor cells, which could be facilitated by modulations of signal transduction 
mechanisms. Therefore, we investigated stress associated signal transduction 
mechanisms, which are associated with UVA or UVB irradiation. Epidermal growth 
factor receptor (EGFR) signaling pathways and insulin like growth factor receptor 
(IGFR) signaling pathways are early targets of UVA signaling. EGFR and IGFR 
receptors are immediately activated upon UV irradiation and these pathways are 
involved in UVA induced metabolic changes in other dermal cells (El-Abaseri et al., 
2006; Lopez-Camarillo et al., 2012). 
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Therefore, the EGFR and the IGFR population were analyzed in melanoma cell lines 
from IM and MM and a significant decrease in the EGFR and the IGFR population on 
the cellular surface upon UVA treatment was detected (figure 22). These results point 
to a higher UVA induced turnover of EGFR and IGFR and to a UVA induced 
internalization and activation of the EGFR and IGFR. Furthermore, the direct 
activation of EGFR upon UVA treatment was verified by Western blot (figure 23). 
EGFR activation leads to activation of pyruvate kinase M2 (PKM2), and then induces 
the expression of glycolytic enzymes, leading to an increased Warburg effect (Yang 
et al., 2012) (Baban et al., in press). Furthermore, EGFR and IGFR induced MAPK 
signaling could lead to transcriptional activation of glycolytic enzymes which are 
capable to facilitate long lasting induction of glycolysis. Further investigations 
concerning MAPK signaling and expression of glycolytic enzymes would be 
necessary to clarify this connection. The protein kinase Akt, involved in 
PI3K/AKT/mTOR signaling (Bunney et al., 2010; Majeweki et al., 2004), is necessary 
for cellular proliferation, progression and invasion. Akt is activated upon UVA 
treatment (figure 24). It has already been shown in melanoma, that Akt activation is 
highly associated with melanoma progression (Dai et al., 2005). Considering this, our 
results support the idea that UVA irradiation enhances progression of initial 
melanoma cells. 
Interestingly, an overexpression of Akt induces elevated glycolytic metabolism, 
furthermore, Akt increased glycolytic metabolism correlates with transketolase 
overexpression (Elstrom et al., 2004; Langbein et al., 2006). 
Generation of ROS, which is one of the intermediate effects of UVA on cells, via 
induction of HIF1, could also lead to metabolic reprogramming towards Warburg 
effect (Haigis et al., 2012). It was shown in melanoma cells that treating with an 
antioxidant (ROS quencher) attenuated HIF1α protein expression and HIF1 activity 
(Kuphal et al., 2010) and inactivation of HIF1α changed the metabolism towards 
oxidative phosphorylation instead of aerobic glycolysis and therefore glycolysis rate 
decreased (Kluza et al., 2012). Upon UVA irradiation a slight induction of HIF1 was 
visible, compared to control (figure 25 and 26) and this induction may be due to 
constitutive HIF1α activation, which could be regulated by ROS in malignant 
melanomas, even in normoxic condition (Kuphal et al., 2010). 
Taken together, our data indicate that UVA irradiation activates EGFR and IGFR as 
well as Akt and HIF1, this activation could influence long lasting induction of 
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glycolysis. Further investigation of the effects of inhibition of EGFR and IGFR 
signaling as well as the inhibition of Akt and HIF1 signaling on UVA induced 
expression of glycolytic enzymes would be necessary to clarify this question.  
 
4. Functional relevance of UVA induced Warburg effect  
Lactate levels of ~16mM were measured upon UVA irradiation of melanoma cells in 
vitro (Baban et al., in press). Lactate concentrations of 11mM are shown in tumors in 
vivo (Serganova et al., 2011). As lactic acid is detrimental for cellular viability, it is 
known that high levels of lactic acid are angiogenic (Dhup et al., 2012) and 
immunosuppressive in monocytes via inhibition of TNF secretion (Dietl et al., 2010). 
In addition, macrophages treated with lactic acid inhibited activation of CD8+ T cells 
(Ohashi et al., 2013) (Baban et al., in press). 
Here we show that high levels of lactic acid have functional relevance as they induce 
transcription and secretion of MMPs and uPA and that UVA irradiation enhances 
invasion of melanoma cells.  
 
4.1 Expression of MMPs and uPA 
It has been shown, that induction of MMP2, MMP3, MMP9, MMP13, MMP15 are 
features of tumor progression (Orimoto et al., 2008) and especially MMP 2, MMP3, 
MMP9, MMP13 and uPA are important proteases during melanoma progression 
(Bianchini et al., 2006; Corte et al., 2005; Girouard et al., 2012; Ji et al., 2013; 
Orimoto et al., 2008; Rotte et al., 2012; Tang et al., 2013; Tas et al., 2008; Tas et al., 
2005; Zigrino et al., 2009). Also it has not been reported that MMP15 transcription is 
induced in melanoma. Here we show that UVA irradiation or lactic acid alone, a 
major derivate of the UVA induced Warburg effect, both are able to induce 
expression of all investigated proteases (MMPs and uPA) (figure 28), which are 
relevant for tumor progression in melanoma cells (Baban et al., in press). 
Furthermore, it was previously shown in other tumors that lactic acid is capable of 
increasing tumor cell migration by activation of MMP2 (Baumann et al., 2009). In our 
experiments, IM cells show a transcriptional upregulation of MMP2, MMP3, MMP9, 
MMP13, MMP15 as well as uPA, compared to untreated control, upon treatment with 
lactic acid (figure 28) in physiological concentrations. In contrast to this, no significant 
upregulation of the inhibitors of MMPs, tissue inhibitor of matrixmetalloproteinases 
(TIMP1), can be found (figure 28) (Baban et al., in press). Downregulation of TIMP 
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with upregulation of MMP3 is found in serum of patients with malignant melanoma 
(Tas et al., 2005). The upregulation of MMPs and uPA is quite rapid, as it happens 
12 hr after addition of lactic acid. So far it has not been reported, that MMP15 
transcription is induced in melanoma. In hypoxic conditions lactic acid can also be 
produced (Pasteur effect), which is observed in melanoma (Scott et al., 2011) and 
many other tumors. Using zymography we are able to show, that either UVA 
irradiation, or UVA irradiation associated lactic acid is capable of inducing secretion 
of active MMP2 and MMP9 (figure 29). UVA irradiation induced secretion of active 
MMP2 and MMP9 was slightly reduced in the presence of ROS quencher (figure 29 a 
and b), indicating a partially ROS mediated mechanism of UVA induced MMP2 and 
MMP9 induction. However, it is important to note that in our system, ROS quenchers 
cannot completely abrogate UVA mediated effects, indicating that either cumulative 
ROS production during UVA treatment exceeds the ROS detoxification capacity of 
Trolox, or other mechanisms, such as activation of MAPK, NFkB, ß-selectin or 
chemokine signaling may also be relevant (Baban et al., in press). 
Furthermore, treatment of cells with lactic acid alone was sufficient to facilitate 
secretion of MMP2 and MMP9 (figure 29). Additionally, UVA irradiation or addition of 
lactic acid alone enhanced secretion of uPA (figure 30) and UVA irradiation 
enhanced secretion of uPA was also partially ROS mediated (figure 30 a). 
Interestingly, lactic acid induced expression of MMPs and invasion in distant areas 
could be one efficient strategy of melanoma cells to run away from unfavorable areas 
with hypoxia, high lactic acid conditions and senescence inducing conditions (Mo et 
al., 2013) (Baban et al., in press). 
 
4.2 Effect of UVA on MMP9 and uPA in skin reconstructs 
UVA irradiation was also able to induce MMP9 and uPA expression in skin 
reconstructs with melanoma cells from IM and MM (figure 38) (Baban et al., in press). 
Although it has to be mentioned, that MMP2 and MMP9 expression in skin 
reconstructs could be derived from keratinocytes and dermal fibroblasts (Eves et al., 
2003). The contribution of keratinocytes and dermal fibroblasts to the MMP9 and uPA 
expression in skin reconstructs could be further investigated with additional 
immunohistochemistry methods.  
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4.3 UVA enhanced Warburg effect increases invasion of melanoma cells via 
production of lactic acid 
The first step in melanoma progression is invasion of adjacent tissue, which is 
facilitated by proteases like matrix metalloproteinase (MMP) and urokinase type 
plasminogen activator (uPA) (described in paragraph 4.1 and 4.2). So far, it was 
reported that MMP9 and uPA are activated during invasion of melanoma cells (Tang 
et al., 2013; Bianchini et al., 2006). 
The role of UVA induced Warburg effect for melanoma progression and invasion 
becomes clear, as we showed that lactate production subsequently led to increased 
expression of MMPs and uPA (figure 28, 29 and 30), resulting in increased 
invasiveness of the UVA treated melanoma cells (figure 31). We are the first to 
provide a functional link between UVA induced Warburg effect with enhanced lactic 
acid production and enhanced expression of MMP and uPA, which finally promotes 
enhanced invasion (Baban et al., in press). 
Our result of the in vitro invasion assay on melanoma invasion showed that UVA 
irradiation significantly increased invasion of melanoma cells and this effect was 
partially ROS mediated, as the ROS quencher Trolox significantly attenuated UVA 
induced invasion (figure 31). Similarly, the inhibitor of glycolysis (2DG) significantly 
attenuated UVA induced invasion (figure 31). Treatment of melanoma cells with lactic 
acid significantly increased invasion to an extent comparable to UVA irradiation. 
These data show, that addition of lactic acid can mimic the UVA induced increase of 
the invasive potential in vitro (Baban et al., in press). 
The presence of MMP inhibitor (GM6001) partially decreased the UVA induced 
invasive potential, as well as the presence of uPA inhibitor (amiloride) partially 
abrogated UVA induced invasive potential (figure 32), indicating that UVA or lactic 
acid induced invasion is partially facilitated either by MMP proteases or by uPA 
protease (Baban et al., in press). These results further strengthen the direct role of 
these proteases in the process of invasion. Taken together, we could show that UVA 
as well as lactic acid alone directly induce tumor relevant proteases, MMPs as well 
as uPA and these proteases are functionally needed for UVA induced invasion in 
vitro (Baban et al., in press). 
We were able to demonstrate, that UVA irradiation enhances the Warburg effect in a 
partially ROS dependent fashion with increased lactate production, which induces 
MMP and uPA transcription, finally leading to increased invasion of tumor cells. This 
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demonstrates, that UVA irradiation is not only important in initiation of melanoma, but 
also during progression. These results support therapeutic strategies of using MMP 
inhibitors together with antioxidants and inhibitors of glycolysis. Furthermore, our 
findings support the therapeutic recommendation of continuous sun protection 
(Baban et al., in press). 
 
4.4 Invasion in skin reconstructs  
It has been reported, that melanoma cells as well as other skin cells are able to 
express MMP9 and MMP2, which are involved in and facilitated melanoma cells 
invasion or progression in the skin reconstruct model (Eves et al., 2003), also was 
shown that invasive potential of melanoma cells in the skin reconstructs is 
determined by the melanoma cells themselves (van Kilsdonk JW et al., 2010). 
Staining of skin reconstruct slices with S100 staining showed that UVA irradiation 
significantly induced initial dermal invasion for IM cells but the effect was not 
significant for MM cells (figure 39). These data obtained with skin reconstructs 
demonstrate that UVA induced invasion of tumor cells, is a process, which is 
essential for melanoma metastasis (Baban et al., in press). 
Taken together, we showed that UVA irradiation induced tumor relevant proteases 
(figure 29 and 38) and MMPs and uPA proteases are involved in UVA induced 
invasion. Since this effect was partially abrogated by MMPs inhibitors, we were able 
to demonstrate, that activity of MMPs is also needed for UVA induced invasion of 
melanoma cells. Furthermore, we could show that upon addition of uPA inhibitor, 
UVA induced invasion was decreased, again indicating that activity of uPA is needed 
for UVA induced invasion of melanoma cells (figure 32) (figure 43) (Baban et al., in 
press).  
UVA 
radiation ROS
Lactate production
Glucose consumption
MMP
uPA
Invasion
Upregulation of Warburg effect
Upregulation of 
extracellular proteases
TIMP
MMP inhibitor
uPA inhibitor
 
(modified from Baban et al., in press) 
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Figure 43. Proposed model for functional relevance of UVA enhanced Warburg effect and 
invasion. 
UVA enhanced glucose consumption and lactate production via production of ROS. Lactate 
production induced expression of MMPs and uPA and led to enhance invasive potential of melanoma 
cells. Furthermore, MMPs and uPA inhibitors attenuated the invasive potential of melanoma cells 
(Baban et al., in press). 
 
 
5. Influence of UVA on different metabolomics 
Reprogramming of metabolic pathways is crucial in cancer cells, in order to adapt 
their bioenergetics and biosynthesis demands for tumorigenesis, progression, to 
escape from immune cells and resistance against chemotherapy (Furuta et al., 2010; 
Dettmer et al., 2013). 
Changes in glycolysis, lipogenesis and tricarboxylic acid cycle in different stages of 
tumor progression were reported, which were associated with amino acid and 
nucleotide biosynthesis (Furuta et al., 2010). 
In collaboration with the University of Regensburg (Prof Gronwald) a large set of 
metabolites that are involved in several major metabolic pathways were analyzed by 
NMR spectroscopy (figure 19, 20 and 21). It has been shown in melanoma cells that 
all exhibited Warburg effect, characterized by increased glucose uptake and lactate 
production, when compared to melanocytes (Scott et al., 2011).  
We determined UVA induced increased Warburg effect through enhanced glucose 
consumption and lactate production in melanoma cells from IM and MM, compared to 
unirradiated control by NMR spectroscopy (figure 19) to support our previous data 
(discussed in paragraph 1.1 and 1.2). 
Metabolism of amino acids (uptake and production) is also changed upon UVA 
treatment in the different melanoma cell lines (WM 115, WM 793 and WM 266-4) 
(figure 20). We detected that UVA irradiation induces L-isoleucine, threonine, valine, 
tyrosine, glutamine, arginine, phenylalanine, leucine and L-pyro glutamic acid in the 
supernatant of IM cells. While in the MM cells only tyrosine, phenyl alanine and L-
pyro glutamic acid were significantly induced, other metabolomics, like formic acid 
and pyruvic acid were also significantly induced by UVA irradiation in different 
melanoma cell lines (figure 20). 
The influence of UVA induced change in metabolites in melanoma cell pellets was 
less (figure 21), when compared to UVA induced metabolites change in the 
melanoma cell supernatant (figure 20). In IM cells no significant change in the 
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concentration of metabolomics was detected, yet the influence on different 
metabolomics in the MM cell pellet was only significant in alanine, lactic acid, formic 
acid, cis-hydroxy D-proline, leucine and adenine (figure 21). 
It was shown, that melanoma cells are producing more alanine from glucose and 
consume more glutamine than melanocytes, and for fatty acid synthesis melanoma 
cells depend on glutamine substrate in hypoxic condition while during normoxic 
condition fatty acids are mostly produced from glucose (Scott, 2011). 
In more detail, the major metabolic pathways such as amino acid synthesis, nucleic 
acid synthesis, glycolysis, glucose and lactate transport, pentose phosphate 
pathway, citrate cycle including 2-hydroxyglutarate, polyamine and methionine cycle, 
urea cycle, tryptophan metabolism, ROS quenchers like glutathione, fatty acid 
metabolism and cholesterol synthesis would be of interest for melanoma metabolism. 
Additionally, production and secretion of components for the extracellular matrix, like 
hyaluronic acid, which is involved in proliferation and migration of tumor cells should 
be monitored by the NMR technique and modifications of this technique. 
Our conclusion, that analysis of metabolic differences in different stages of 
melanoma cells and primary cells may provide novel treatment options for a 
therapeutic benefit in melanoma cancer patients. 
 
6. Common deletion 
The importance of mitochondrial DNA (mtDNA) damage during carcinogenesis has 
recently been critically discussed with reports of varying mtDNA deletion frequencies 
in different tumors. High frequencies of the mtDNA 4977bp deletion, that is called 
common deletion, are associated with aging, especially photoaging (Berneburg et al, 
2004; Hubbard K et al., 2008). 
In non melanoma skin cancer (squamous cell carcinoma and basal cell carcinoma) 
different types of mtDNA damages were investigated including mtDNA 4977bp 
deletion (Durham et al., 2003) and the amount of mtDNA 4977bp deletion in 
squamous cell carcinoma and basal cell carcinoma, showed that most of these 
tumors had a decreased or undetectable amount of mtDNA 4977bp deletion, 
compared to prelesion non tumor tissue (Eshaghian et al., 2006; Kamenisch et al., 
2006). 
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It has been shown in normal skin (non melanoma tissue) of melanomas patient, that 
the prevalence rate of mtDNA common deletion in darker skin was less than in those 
of lighter skin (high risk group of melanomas) (Hubbard K et al., 2008). 
The frequency of the mtDNA 4977bp deletion in melanoma tissue is still unknown 
and a possible role of this deletion in melanoma and other tumors is still discussed 
controversially. 
It has been shown in some tumors, for example in oral cancer and colorectal cancer 
that the frequency of deleted mtDNA is decreasing proportionally during disease 
progression (Shieh et al., 2004; Chen et al., 2011). Recently, it has been 
demonstrated that melanoma cells in an advanced stage have elevated rates of 
oxidative phosphorylation, compared to melanocytes (Barbi de Moura et al., 2012). 
Furthermore, it is known that mitochondrial function plays a prominent role in 
producing the energy, ATP through respiration, as well as in cellular metabolism. 
However, mitochondria has many other functions in addition to the production of 
ATP. 
Our findings indicate that the increased level of mtDNA 4977bp deletion may be a 
transient phenomenon during early stage of melanomagenesis to advanced stage of 
melanoma, which predominately disappears later on. 
The potential role of common deletion in the initial phase of melanoma as initial 
melanoma promoting factor and functional relevance of common deletion in initial 
phase of melanoma is still unclear and needs further investigation. 
The frequency of the mtDNA common deletion in melanomas as wells as nevi is still 
unknown. Especially dysplastic nevi are an important risk factor for the development 
of melanoma. The aim of this study was to investigate the frequency of the mtDNA 
4977bp deletion in melanomas of initial and advanced stages and in normal and 
dysplastic nevi. To accomplish this, samples were collected from four different 
groups of patients with normal nevi, dysplastic nevi, initial melanomas with tumor 
thickness smaller than 1mm and advanced melanomas with tumor thickness larger 
than 4mm.   
Each group consisted of at least 20 patients and tissue adjacent to the lesion of each 
individual patient of each group, was used as control.  
Tumor and non-tumor samples were confirmed by an independent pathologist, 
stained with hematoxylin and eosin (H&E) stain and then laser capture 
microdissected with a Laser capture microdissection (LCM2105) device to avoid 
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contamination with adjacent tissues of each sample. The frequency of common 
deletion in each sample was normalized to the respective control tissue of each 
individual patient. In most of the normal nevi, the dysplastic nevi and initial 
melanomas the frequency of the common deletion was higher when compared the 
adjacent control tissue (figure 40 and 41). The average frequency of common 
deletion in nevi samples was approximately 51 times higher than in adjacent control 
tissue (figure 40).  
This tendency was also visible in the group with dysplastic nevi with an average 
increased frequency of approximately 93 times and in the group with initial 
melanomas with an average increased frequency of approximately 100 times (figure 
40). Interestingly, the frequency of common deletion decreased dramatically in 
advanced stages to an average decreased frequency of approximately 0.5 times 
compared to adjacent control tissue (figure 40). This decrease in the frequency of the 
common deletion was highly significant, when compared to the frequencies of nevi 
and initial melanoma and high amount of mtDNA 4977bp deletion could be a 
transient phenomenon during early stages of melanomagenesis since we found a the 
tendency to higher amounts of common deletion, compared to epidermal tissue in 
nevi and dysplastic nevi.  
High metabolism rates of advanced melanoma may also be a possible explanation, 
why these cells in metastasizing melanoma can afford lower levels of the common 
deletion, compared to initial melanoma cells. This appears reasonable, as 
proliferating cells, such as tumor cells, need an abundant supply of energy during 
proliferation and metastasis. 
This finding indicates a possible selection mechanism during melanoma progression 
against high levels of common deletion and its depletion in advanced melanomas 
could serve as a tumor marker. 
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Abbreviations 
 
Description 
% Percentage 
°C Degree celsius 
18F Fludeoxyglucose  
2-DG 2-Deoxy-D-glucose 
3D Three dimensional 
6-4PPs (6-4) photoproducts 
8oxoG 8-oxo-7,8-dihydro-2'-deoxyguanosine  
AKT/mTOR  AKT/mammalian target of rapamycin 
ATP Adenosine triphosphate  
BCC Basal cell carcinoma  
BER Base excision repair  
bp Base pair 
C-T or CC-TT 
transitions 
Cytosine-thymine or Cytosinecytosine-
Thyminethymine transitions 
CC dimers Cytosinecytosine dimers 
cCdk4 Cyclin dependent kinase 4 genes  
CD Common deletion  
cDNA cComplementary DNA (cDNA) 
CO2 Carbon dioxide 
CPDs Cyclobutyl pyrimidine dimers  
dl Deciliter 
DMBA 7,12-dimethyl benz anthracene  
DMEM Dulbecco’s Modified Eagle Medium  
DMSO Dimethylsulfoxide  
DNA Deoxyribonucleic acid 
DSBs Double strand breaks  
EGFR Epidermal growth factor receptor  
ELISA Enzyme linked immunosorbent assay  
ERK  Extracellular signal regulated kinases 
FACS Fluorescence activated cell sorting  
FBS Fetal bovine serum  
g Gram 
GAPDH Glyceraldehyde3-phosphate dehydrogenase 
GLUT1 Glucose transporter 1  
H&E stain Hematoxylin and eosin stain 
H+ Hydron 
H2O Water 
HGF/SF Hepatocyte growth factor/scatter factor  
HIF1α Hypoxia inducible factor 1 alpha  
HR Homologous recombination 
hr Hour 
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HRP Horseradish peroxidase  
IFNgamma/TNFalpha Interferon gamma/tumor necrosis factor alpha 
IGFR Insulin-like growth factor receptor  
IM Initial melanoma 
IR Ionizing radiation  
IS Internal standard 
J/cm2 Joule/ square centimetre 
l Litre 
LDH Lactate dehydrogenase enzyme  
MAPK Mitogen activated protein kinases 
MET gene Metallothionein gene 
min Minute 
ml Millilitre 
mm Melimeter 
MM Metastasizing melanoma 
mm2 Square millimetre 
mmole Millimole 
MMP1 Matrix metalloproteinase 1  
MMP10 Matrix metalloproteinase 10  
MMP15 Matrix metalloproteinase 15  
MMP13 Matrix metalloproteinase 13  
MMP2 Matrix metalloproteinase 2  
MMP3 Matrix metalloproteinase 3  
MMP9 Matrix metalloproteinase 9  
mRNA Messenger RNA  
mtDNA Mitochondrial DNA  
MTT  (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) 
NAD+ Oxidized nicotinamide adenine dinucleotide 
NADH Reduced nicotinamide adenine dinucleotide  
NADP+ Oxidized Nicotinamide adenine dinucleotide 
phosphate 
NADPH Nicotinamide adenine dinucleotide phosphate  
nDNA Nuclear DNA   
NER Nucleotide excision repair  
NHEJ Non homologous end joining  
nm Nanometer 
NMR spectroscopy Nuclear magnetic resonance spectroscopy 
NOS Nitric oxide syntheses  
NOX Nicotinamide adenine dinucleotide phosphate 
oxidase 
O.D Optical density  
O2 Oxygen  
p53 gene Tumor protein gene 
PARP1 Poly ADP ribose polymerase 1  
PBS X1 Dulbecco’s phosphate buffered saline 1x  
PCR Polymerase chain reaction  
PDK3 Pyruvate dehydrogenase kinase 3  
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Table 20. Abbreviation and their definition. 
!
PET Positron emission tomography 
pg Picogram 
PI3K Phosphor inositide 3 kinase 
PTEN Phosphatase and tensin homolog  
PVDF Hydrophobic polyvinylidene difluoride 
RAS Rat sarcoma  
RGF Radial growth phase 
RNA Ribonucleic acid  
ROS Reactive oxygen species  
rpm Round per minute 
rRNA Ribosomal RNA  
RT Room temperature  
RT-PCR Reverse transcription polymerase chain 
reaction  
RTK Receptor tyrosine kinase  
RTK rRceptor tyrosine kinases 
SCC Squamous cell carcinoma  
sec Second 
siRNA Small interfering RNA  
SOD Super oxide dismutase  
SPECT Single-photon emission computed tomography 
SSBs Single strand breaks  
T-G transversions Tyrosine-Guanosine transversions 
TC/CT dimers Thyminecytosine/cytosinethymine dimers 
TIMP Tissue inhibitor of metalloproteinasses 
TKT 1 Transketolase like 1  
tRNA Transfer RNA  
TT dimers Thyminethymine dimers 
uPA Urokinase plasminogen activator  
US 
 
United States 
UV Ultraviolet  
UVA Ultraviolet A  
UVB Ultraviolet B  
UVC Ultraviolet C  
VGF Vertical growth phase 
WHO World health organization  
XP Xeroderma pigmentosum  
β actin Beta actin 
µg Microgram 
µl Microliter 
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